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ABSTRACT 
The effect of cocktail or “pre-workout” supplements containing L-arginine nitrate and 
caffeine are equivocal with anaerobic performance. The purpose of this study was to compare 
anaerobic performance and blood flow of pre-workout supplement containing L-arginine-nitrate 
and caffeine-to-caffeine and placebo. In a randomized, double-blind study, 12 resistance-trained 
males (caffeine users) completed three trials. Biodex concentric-concentric elbow-flexion and 
extension (5-sets, 10-repetitions). Ultrasound measured brachial blood flow (M-Vel, V- r2 and V-
C). Statistical analyses revealed a significant difference in total dynamic work PRE-PLA 
(P<0.0001) and CAF-to-PLA (P<0.0001) but not PRE-to-CAF (P=0.9581). Furthermore, a 
significant difference V- r2  PRE-to-CAF (P=0.0391) and PLA-to-CAF (P=0.0070) and M-Vel 
PRE-to-CAF (P=0.0281). Conclusion, PRE did not differ CAF in strength measures other than a 
difference in M-Vel. PRE compared to PLA were not statically different in blood flow. The study 
illustrated no improvement beyond individual ingredient. This research may be useful for future 
cocktail supplement and Nitric Oxide research. 
Keywords: Cocktail mixtures, L-arginine, NO, Anaerobic exercise, ergogenic-aid 
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LIST OF DEFINITIONS 
Aerobic exercise……………………Exercise that relies on oxygen-dependent energy produced 
through slow substrate reduction, also referred to as 
endurance exercise (Katch, McArdle, & Katch, 2011, 
p152) 
Anaerobic exercise………………….Exercise that relies on the fast chemical reactions to reduce 
energy substrates without oxygen, usually less than 90 
seconds (Katch et al., 2011, p. 152) 
Angiotensin II………………………A powerful stimulant that increases blood pressure by 
stimulating the release of aldosterone, stimulating 
sympathetic nerves, and causes vasoconstriction or 
narrowing of the blood vessel (Fyhrquits, Metsärinne, and 
Tikkanen, 1995) 
Clearance……………………………Removal or withdraw from a substance to potentially return 
to a state before consumption (Graham, 2001a) 
Cocktail……………………………..Combination of individual nutritional supplements or 
ergogenic compounds mixed within a formula among the 
field of sports nutrition 
Concentric…………………………..Concentric muscle contraction occurs when skeletal muscle 
shortens resulting from increased tension on the muscle or 
muscle groups. This contraction is the most common in 
weight-bearing exercise (Katch et al., 2011, p. 446) 
Eccentric……………………………Eccentric muscle contractions occur when skeletal muscles 
lengthen in response to resisting tension (Katch et al., 2011, 
p. 447) 
Forearm Blood Flow (FBF)………...Is a regional area that blood flow is measured from the 
superficial portion of the brachial artery (Daniels et al., 
1999) 
Intoxication………………………...Consumption of a substance beyond recommended dosage 
that results in side effects, adverse effects, injury, or death 
Isokinetic…………………………...Muscular action that maintains constant speed in space 
(Katch et al., 2011) 
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Nutritional supplement……………..Agent or procedure added to complete, extend, or reinforce 
nutrition (supplement, supplemented). Aspect: “sports 
nutritional supplement” a designed, specialized nutritional 
supplement to support: metabolism, energy, athletic 
performance and recovery (Buell et al., 2013; Katch et al., 
2011) 
One repetition maximum (1RM).…..A dynamic exercise test that assesses concentric and 
eccentric maximum lifting capacity (Katch et al., 2011, p. 
448) 
Resistance training (RT)……………Resistance training is physical activity that improves 
muscular fitness among exercised muscle groups with 
external resistance, also referred to as strength training 
(American College of Sports Medicine, 2013) 
VO2max…………………………….This is the maximum amount of oxygen uptake the can 
occur during exercise, also referred to as maximal oxygen 
uptake (Katch et al., 2011, p. 192) 
VO2peak…………………………….Point at which VO2max levels (peaks) during a maximal 
exercise test, this value is the highest amount of oxygen 
uptake (Katch et al., 2011, p. 222), commonly VO2max and 
VO2peak are used interchangeably 
Wingate test………………………...Involves 30 seconds of all-out exercise on either an arm or 
cycle ergometer, with weight determined by body mass 
which applies friction to the cycle, and enables the 
calculation for peak power output and average power 
output (Katch et al., 2011, p. 208)  
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CHAPTER 1. INTRODUCTION 
Nutritional supplements are an estimated $32 billion-dollar industry annually in the 
Unites States (Forbes Magazine) (Lariviere, 2013).  Industry leaders such as MusclePharm reach 
near hundreds of millions of dollars in revenue each year, purchased by consumers, many 
younger, for use in improved results from workouts, often called “pre-workout” supplements.  
The nutritional supplement industry is poorly regulated particularly in the areas of supplement 
safety, efficacy, and purity (Buell et al., 2013). The Food and Drug Administration (FDA) is not 
required to evaluate nutritional supplements before they are made available to consumers (FDA, 
2015). In addition, supplements are not removed from the market until the reported risks 
outweigh the products advertised (or “on the label”) purpose (FDA, 2015). Especially among 
competitive athletes, purity is important. Unknown ingredients could result in disqualification 
from competition. Unknown purity could also result in unknown side effects, even death (e.g. 
from ephedra containing supplements in the last decade). In the recent decade, FDA regulations 
go unchanged. Compounding the problem, most supplements available to recreationally active 
individuals are mixtures of ingredients rather than pure substances making it difficult to test for 
safety, efficacy, and purity for single ingredients (Buell et al., 2013).  
These multi-ingredient mixtures are often called: energy drinks, dietary supplements, 
mixed supplements, “pre-workout”, “cocktail” supplements, and many others. The combination 
cocktail mixed supplements that contain unknown doses of individual ingredients per dose, 
making it challenging to compare one product among other pre-workout supplements (Kedia et 
al., 2014; Smith et al., 2010; Spradley et al., 2012; and Outlaw et al., 2014). Furthermore, the 
research related to common pre-workout ingredients such as nitric oxide warrants investigation 
into testing as individual substances to show improved ergogenic potential (Bescós et al., 2012; 
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Bailey et al., 2010; Camic et al., 2010a; Camic et al., 2010b). Caffeine, another common 
ingredient in pre-workout supplements, has been an individual ingredient shown to potentially be 
ergogenic both in combination with cocktail mixtures and alone. 
Statement of the problem 
This inability to test for safety, purity, and to test for efficacy of the ergogenic potential 
of individually combined ergogenic substances is under-researched and needed. The combined 
effects of such mixtures may result in unwanted side effects, injury, or death (Bunsawat et al., 
2014; Jacobs et al., 2003). 
Purpose of the study 
The purpose of this literature review is to identify the need to investigate both 
combination mixtures as well as individual mixtures.  Therefore, investigation into the ergogenic 
potential of the combination L-arginine nitrate and caffeine in comparison to caffeine alone or 
placebo will be reinforced.  
Hypothesis of the study 
The hypothesis of this research is that a single dose of caffeine will not illustrated 
difference from a combined mixture including a similar dose of caffeine in compared short term 
effects, anaerobic (ergogenic) performance, or blood flow measures. 
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CHAPTER 2. LITERATURE REVIEW 
Introduction 
Nutritional ergogenic aids, also referred to as performance enhancing substances, dietary 
substances or practices are not a new idea (Katch, McArdle, & Katch, 2011; Mahan, Escott-
Stump, & Raymond, 2012). Athletes, whether professional, collegiate, or recreational, 
commonly use dietary supplements, however, all supplements are not, and should be evaluated 
for efficacy and safety (Buell et al., 2013). In recent years, all types of ergogenic nutritional aids 
have increased in availability. Gaining in popularity, ergogenic nutritional mixtures, which are a 
combination of consumable dietary supplements, have been called cocktails (Spradley et al., 
2012). These cocktail mixtures combine separate ergogenic substances that may improve 
performance alone but are generally not tested together. To better understand how cocktail mixes 
effect ergogenic potential, research is needed comparing specific cocktail mixtures to individual 
ingredients to identify ergogenic potential and safety beyond individual ingredients alone. The 
purpose of this literature review is to examine the potential ergogenic effects separately, safety 
and efficacy of single ingredients caffeine, and L-arginine nitrate alone, to estimate effects of the 
combined mixture. 
Cocktail pre-workout supplement 
Cocktail mixtures marketed as pre- and post-workout supplements are often specific to 
anaerobic training or resistance training (Kedia et al., 2014). A specific research focus has been 
on pre-workout supplements and investigated by several teams (Kedia et al., 2014; Hoffman et 
al., 2008; Smith, Fukuda, Kendall, & Stout, 2010; Spradley et al., 2012; Outlaw et al., 2014). It is 
difficult to show interrelation among studies because none of the listed studies used the same 
mixture products in research design.  
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Kedia et al. (2014) used a double-blind randomized trial that consisted of two segments 
of resistance trained male and female participants (n=40, 26 ± 5.3 years). The measure of 
resistance training was three workouts per week for more than or equal to 2 years. This study did 
not use a gender divided participant group. The investigational study used a multi-ingredient 
(cocktail mixture) pre-workout supplement measuring the safety in segment 1 (Kedia et al., 
2014). Kedia et al. (2014) used the first segment to identify an acute ingestion of the cocktail 
mixture and measured the effects on blood measures including blood pressure (BP), heart rate 
(HR), and heart rate variability. The HR and BP were measured at baseline and then repeated 
every 30 minutes post consumption, whereas the heart rate variability was measured pre-
ingestion and 180 minutes post by 12-lead ECG, using Friedericia’s formula (QTc=QT/3√RR). 
The participants were excluded from both segments if they reported a history of taking dietary 
supplements such as creatine or betaine (both found in the multi-ingredient supplement) within 
30 days of the study (Kedia et al., 2014). The participant inclusion criteria did not restrict, 
measure, or control caffeine intake during the study. The results of segment 1 reached statistical 
significance (p<0.01, and p<0.05) with increases in both Systolic Blood Pressure, SBP (3.4-5.4 
mmHg) and Diastolic Blood Pressure, DBP (2.3-42 mmHg), respectively, within supplement 
participants, with intervention. These results did not reach significance in the intergroup 
comparison as well the ECG results did not influence intergroup difference (p<0.11).    
The second segment of the Kedia et al. (2014) study was a 6 week resistance training 
program 4 days per week. Participants (n=43, 24.3 ± 2.9 years) used a blinded supplement 
consumed 30 minutes prior to exercise after a 10 hour fast. The investigators did not discuss the 
difference between participants in segment 1 and 2. The exercise program consisted of 10 to 12 
exercises per day at 3 sets by 12-15 repetitions (Kedia et al., 2014). The program measured 
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muscular performance at week 3 and week 6, with 1RM bench press and calculated muscular 
endurance (volume and total number reps during 1RM) (Kedia et al., 2014). Lower extremity 
muscle performance was not assessed in this study. The comparison of statistical analysis was 
between-group (supplement and placebo) with independent sample t-tests. The results of 
muscular performance did not reach statistical significance intergroup with the exception of 
repetitions to failure within supplement group from baseline in week 3 (p<0.01). The efficacy of 
supplement use was assessed by differences in perceived energy both at week 3 (p=0.006, set 2 
and =0.024, set 3) and week 6 (p=0.034, set 2 and =0.040, set 3) via self-questionnaire. Other 
measures of efficacy included side effects ranging from headache, upset stomach, and insomnia 
(Kedia et al., 2014). Results suggest that a multi-ingredient (cocktail) supplement taken before 
exercise may improve athletic performance during exercise (Kedia et al., 2014).  
Hoffman et al. (2008) investigated the acute hormonal effects of a “pre-exercise energy 
supplement” on resistance trained males (n=8, 20.3 ± 1.6 years). Participants were screened for 
nutritional supplements for study eligibility but were not controlled or screened for habitual 
caffeine intake. These investigators did, however, effectively list the dose of individual 
ingredients in the commercially available supplement (Amino Shooters™ by Champion 
Nutrition Inc.) (Hoffman et al., 2008, pg 878). The ingredients contained in that cocktail mixture 
are listed in Table 1. The experiment consisted of 5 total sessions (testing, protocol, loading, and 
two post-testing) in a double-blind crossover design that comparatively examined the 
hemodynamic (or physical blood make-up), effects pre and post exercise (Hoffman et al., 2008). 
The exercise entailed 1RM back squat (initial session), followed by familiarization sessions 
(second and third) of 6 sets by ≤10 repetitions of back squat (at 75% 1RM) with 2 minutes 
between sets (Hoffman et al., 2008).  
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Table 1  
Pre-workout (cocktail mixture) ingredients 
      
      
Hoffman et al. (2008)                                               
(n=8) serving size 19 g  
Spradely et al. (2012)                                       
(n=12) serving size 23 g (1/2 scoop) 
Total caffeine content 110 mg   Total caffeine content unknown 
Amino Shooters™ 
ingredients:   Assualt™ ingredients:   
Branch chain amino acids (3000 mg L-leucine, 1100 mg L-
isoleucine, and 1100 mg valine) 
Total carbohydrate 9 g   
  Vitamin B6 14 mg  
  Vitamin B12 85 µg  
Essential amino acids (1100 mg L-lysine, 300 mg L-
methionine, 1100 mg L-
phenylalanine, 700 mg histidine, 
1100 mg L-threonine) 
Calcium 247 mg  
  Sodium 45 mg  
  Potassium 40 mg  
Creatine monohydrate 5000 mg 
Assualt proprietary 
blend 23000 mg  
L-taurine 1500 mg    CarnoSyn® Beta-alanine, citrulline malate, (DMG) 
Dimethylglycerine, rhodiola rosea root, creatine 
monohydrate, Con-Cret®, creatine HCl, **caffeine 
anhydrous, BCAAs     (L-leucine, L-valine, L-
isoleucine), L-glycine, **L-arginine blend (L-
arginine AKG, Di-arginine malate, L-arginine 
HCl), Astragin®, Cinnulin®, L-glutamine, 
phosphorus, sodium, potassium, and other 
ingredients    
Glucuronolactone 350 mg    
Caffeine 110 mg    
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7 
The familiarization was followed by a 1 week creatine-loading of 20 g/day before the 
final two crossover testing sessions (similar to familiarization) where the supplement and/or 
placebo was consumed 10 minutes prior to exercise. The creatine-loading phase was used in 
addition to the tested supplements prior to exercise test sessions. The investigators then measured 
acute hormonal effects with blood draws pre-exercise, immediately post exercise, as well as 15 
and 30 minutes post-exercise (Hoffman et al., 2008).  
Other than a statistically significant increase (p ≤ 0.05) in total number of repetitions in 
set 5 the results of this study did not comprehensively compare dose to anaerobic exercise or 
ergogenic potential (Hoffman et al., 2008). The author did not provide the exact p-value but total 
work volume was higher in supplement groups. The volume of exercise was estimated from 
blood lactate concentration with an eight percent increase (p = 0.07) in supplement compared to 
placebo group immediately post-exercise. Furthermore, there was a significant increase (no p-
value provided) in acute growth hormone. The response increased from pre-exercise to both 15 
and 30 minutes post-exercise in supplement group whereas placebo increased pre-exercise to 30 
minutes post only (Hoffman et al., 2008). The total testosterone concentration increased pre- to 
post-exercise but did not reach statistical significance (no p-value provided). There were no 
reports of unwanted side effects. This suggests that the supplement may increase the response of 
growth hormone and testosterone during exercise but require further investigation.  
Smith et al. (2010) identified the effects of a pre-workout supplement on both aerobic and 
anaerobic performance in a randomized parallel trial that was single blinded. The experimental 
design incorporated the supplement use into a 3 week training program of high-intensity interval 
training (HIIT) with moderately trained recreational athletes (n=24, 21.1 ± 1.9 years). The pre-
workout supplement Game Time® (Corr-Jenson Laboratories Inc, Aurora, CO) contained a 
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proprietary blend of whey protein, creatine, citrulline, ginseng, caffeine 100 mg, and additional 
ingredients (Smith et al., 2010). The participants were screened for prior caffeine and supplement 
use however these surveys were not discussed. Eighteen total sessions were used throughout the 
study detailed below (Smith et al., 2010). The trial familiarized the participants on three separate 
sessions prior to the initiation of baseline testing in sessions four, five, and six. The baseline 
testing measured VO2max with exercise treadmill protocol beginning at 10 km/h and 0% grade 
increasing 2 km/h every two minutes until participant reached 16 km/h and following with 1 
km/h increase per minute until 18 km/h was achieved (Smith et al., 2010). The VO2max was 
instrumentally measured with a metabolic cart (True One 2400® Metabolic Measurement 
System, Parvo-Medics Inc., Sandy, UT).  
After testing the participants began the HIIT program 3 days per week for 3 weeks, 
beginning each training session pre-fasted (4 hours) and 30 minutes after ingesting the 
supplement or placebo prior to exercise (Smith et al., 2010). The HIIT consisted of a treadmill 
run with a series of 5 sets by 2 minutes in repetitions (with 1 minute of rest) at 90% VO2max 
from baseline measure (Smith et al., 2010). The VO2max (l/min) results reached significance (p 
= 0.028) in comparison to time baseline to post-test in both supplement and placebo groups. The 
total training volume increased in the supplement group reaching significance (p = 0.041) over 
placebo. This study did not discuss possible side effects of the Game Time® supplement. The 
consensus of this study suggests that performance related to cardiovascular and VO2max is 
improved by the consumption of this supplement (Smith et al., 2010).  
Spradley et al. (2012) examined the acute ergogenic potential of pre-workout supplement, 
Assault™ (MusclePharm, Denver, CO) on muscular endurance, anaerobic capacity, and aerobic 
capacity. The ingredients are listed in Table 1. This experiment used a randomized double-blind 
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design with crossover investigation in recreationally trained males (n=12, 28 ± 5 years). For 
eligibility participants were required to refrain from nutritional supplements for 6 weeks prior to 
the study and for the duration of the study (Spradley et al., 2012). There was no evidence of 
dietary screening or habitual caffeine use before the study. However, participants were asked to 
record a 2-day food diary before the first test session in order to repeat that diet before the 
following testing session and to report 12 hours fasted for testing (Spradley et al., 2012). The 
participants completed three different visits, including a baseline familiarization and two 
following test sessions. This investigation measured ergogenic performance with; muscular 
reaction measured by martial arts protocol, muscular strength measured by 1RM for both free 
bench press, seated leg press, muscular endurance measured by 75% 1RM, 1 set ≥5 reps, aerobic 
and anaerobic capacities (modified treadmill protocols) (Spradley et al., 2012). The supplement 
(see Table 1, for dose) or placebo was ingested 20 minutes prior to exercise and heart rate and 
blood pressure was measured pre-ingestion, 20 minutes post, and post-exercise. Meanwhile 
participants were asked to complete a short 4 question Likert-scale survey on feelings of: energy, 
alertness, focus, and level of fatigue (Spradley et al., 2012). There was no mention of the number 
of times participants filled out the questionnaire.  
After investigation, the results were skewed towards the supplement group. Participants 
in the supplement group on average had higher heart rates 102 ± 12 compared to the placebo 
group 94 ± 15 (p < 0.05) (Spradley et al., 2012). In addition, leg press repetitions reached 
significance (p < 0.05) in supplement group 13 ± 6 compared to placebo 11 ± 3. Finally, the 
questionnaire revealed differences between supplement and placebo (respectively): energy 3.6 ± 
0.8, 2.7 ± 0.5; alertness 4.0 ± 0.7, 3.6 ± 0.8; focus 4.1 ± 0.6, 3.6 ± 0.8; and fatigue 2.6 ± 0.8, 3.7 
± 0.7 (p < 0.05) (Spradley et al., 2012). This investigation suggests that ergogenic performance 
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except for aerobic capacity (VO2max) is improved with consumption of this multi-ingredient 
cocktail supplement.  
Outlaw et al. (2014) used a randomized double-blind, match-pair design to investigate 
anaerobic ergogenic potential of a pre-workout supplement containing creatine monohydrate, 
beta-alanine, L-taurine, L-leucine, and caffeine. This study included resistance trained males 
(n=20, 22.4 ± 9.5 years) that were required to bench 1.2 and leg press 2.5 times individual body 
weight (Outlaw et al., 2014). There was no inclusion or exclusion criterion for habitual caffeine 
use other than nutritional supplements. The study used a 9-day food diary, as pre-dietary 
screening that was analyzed by lab personnel using The Food Processor (ESHA Research, 
Salem, OR) (Outlaw et al., 2014). Baseline testing consisting of vertical jump, 1RM bench, 
muscular endurance bench (repetitions to failure at 85% 1RM), 1RM leg press, muscular 
endurance leg press (repetitions to failure at 85% 1RM) and a Wingate cycle ergometer test 
(Outlaw et al., 2014). The investigators then matched and randomized participants into 
supplement or placebo training groups. The pre-workout supplement (or placebo) was consumed 
30 minutes prior to resistance exercise.  
The training program consisted of four sessions of split body workouts (upper and lower) 
with 10 exercises per session at 3 sets by 8 repetitions targeting 80% of baseline 1RM (Outlaw et 
al., 2014). The rest ratio for the training program was 1 to 2 minutes between sets and minutes 
between exercises respectively. The training program lasted seven days in total at which time 
participants retested the previous exercise tests (Outlaw et al., 2014).  The overall results showed 
significance within time effect for peak power measured in Watts (Wingate test, p =0.001; ηp2 = 
0.550), bench 1RM (p = 0.001; ηp2 = 0.448), and leg press 1RM (p = 0.001; ηp2 = 0.632) (Outlaw 
et al., 2014). However there were no differences between group comparisons. The data of this 
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study suggests that a pre-workout supplement has the potential to improve performance during 
anaerobic exercise.   
Table 2  
Caffeine supplement ingredients contained in one dose of cocktail mixtures described by Beck 
et al. (2006); Beck et al. (2008) (3 pills) 
Ingredients Beck et al. (2006) (n=37) 
Beck et al. (2008) 
(n=31)     
Total caffeine content 201 mg 201 mg (201 mg) 
Yerba Mate  500 mg 500 mg (40 mg caffeine) 
Guarana seed extract  422 mg 422 mg (152 mg caffeine) 
Black tea extract  100 mg 100 mg (9 mg caffeine) 
Ginger extract  500 mg 500 mg    
Schisandra chinensis fruit 
extract  100 mg 100 mg    
Dill weed extract  5 mg 5 mg    
Grape seed extract  1 mg 1 mg    
Vitamin C  120 mg 120 mg    
Niacin  20 mg 40 mg    
Vitamin B6  2 mg 2 mg    
Pantothenic acid  10 mg 10.4 mg    
Vaccininium angustifolium 
 (Wild blueberry extract, 
Vitablue) 
50 mg 100 mg 
   
   
Cinnamon  25 mg 25 mg    
Red pepper extract - 10 mg    
Black pepper extract - 5 mg     
 
 Several studies used cocktail mixtures not related to pre-workout supplements but 
focused on caffeine as an ingredient (Beck et al., 2006; Beck, Housh, Malek, Mielke, & Hendrix, 
2008; Forbes, Candow, Little, Magnus, & Chilibeck, 2007). Beck et al. (2006) tested a caffeine 
containing supplement (1 dose = 3 tablets, = 201 mg) compared to placebo (Table 2). This 
investigation used a randomized, double-blinded parallel design with resistance trained males 
(n=37, 20.8 ± 2.0 years). The purpose was to measure anaerobic performances markers including 
Wingate, 1RM on bench press, 1RM on seated leg press, and muscular endurance of both bench 
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press and seated leg press (Beck et al., 2006). Muscular endurance was measured with 1 set to 
fatigue at 80% 1RM, 2 minutes post 1RM.  
The participants were not allowed to consume nutritional supplements within 6 weeks 
and throughout the duration of the study (Beck et al., 2006). The participant habitual caffeine use 
was not controlled or accounted for in this study. Beck et al. (2006) conducted three total visits 
starting with baseline testing, followed by 2 supplementation visits. Participants performed 2 
consecutive Wingate tests one hour after supplement or placebo ingestion. The participants 
returned for the final visits (≥ 24 hours) after Wingate measures were taken. The final visit 
concluded testing with both 1RM and muscular endurance for both bench and seated leg press 
(Beck et al., 2006). The outcome of this investigation illustrated a 2.1% increase in bench 1RM 
in supplement compared to placebo reaching significance (p ≤ 0.05) (Beck et al., 2006). Bench 
muscular endurance increased 5% but did not reach significance (p = 0.074) (Beck et al., 2006). 
The caffeine containing supplement had no effect on the remaining measures compared to 
placebo. This suggests that the supplement is a potential ergogenic aide and caffeine can 
hypothetically increase bench 1RM performance.   
 The later research by Beck et al. (2008) was a follow-up study to the previous study by 
Beck et al. (2006). This study was a double-blinded, and crossover design that examined the 
anaerobic and aerobic potential of a caffeine supplement (201 mg) compared to placebo on 1RM 
bench press, and running treadmill test running to volitional exhaustion at 85% of VO2peak in 
untrained males (both resistance and aerobic, n=31, 23.0 ± 2.6 years) (Beck et al., 2008). 
Caffeine intake was not screened or controlled for throughout the investigation. Beck et al. 
(2008) used a similar supplement “cocktail mixture” from Beck et al. (2006). Individual 
ingredients appear in Table 2. Baseline testing included predicted VO2peak during a treadmill 
 
 
13 
 
protocol starting participants at 6.44 km/h, 0% grade increasing 1.61 km/h every two minutes 
until 14.49 km/h after intensity increased by 2% grade every two minutes concluding at 
volitional exhaustion (Beck et al., 2008). The VO2peak was measured by TrueMax metabolic 
cart (Parvo Medics, Sandy, UT). During testing participants consumed a randomized trial 
(supplement or placebo) and ingested 45 minutes before exercise. The results showed no 
significant mean differences between supplement and placebo for 1RM bench or treadmill 
testing (Beck et al., 2008). This suggests a possible link between ergogenic potential, trained 
versus untrained individuals, and the effectiveness of caffeine as an ergogenic performance aid 
on select population.  
The caffeine supplement (3 pills) used in Beck et al. (2008) contained red pepper extract, 
and black pepper extract which was not consistent with the previous study (Beck et al., 2006). 
The dose of niacin, and pantothenic acid varied within the two Beck studies 40 mg, and 10.4mg 
respectively (Beck et al., 2008) compared to 20 mg and 10 mg respectively (Beck et al., 2006). 
Forbes et al. (2007) investigated the use of a caffeinated energy drink (Red Bull®) and 
effects on anaerobic power by Wingate cycle test and muscular endurance on physically active 
male (n=12) and female (n=4) participants. The age and standard deviation of participants both 
male and female was 24 ± 6 years. Physical activity was self-reported equating to moderate 
activity 2 to 3 days per week as well participants completed Physical Activity Readiness 
Questionnaire (PAR-Q) (Forbes et al., 2007). The dietary intake was not screened controlled for 
throughout the study. Other than the researcher staff requesting participants not to change any 
dietary patterns (Forbes et al., 2007). However researchers screened participants for habitual 
caffeine intake through self-reported questionnaire. The questionnaire revealed that some 
participants (n=8) reported caffeine naïve 0 mg·d-1, n=4 <100 mg·d-1, and n=3 >200 mg·d-1 
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(Forbes et al., 2007). This investigation used a double-blinded, crossover design and previous 
listed performance measures. Blood lactate values were also measured but not reported in 
methods section. The participants attended 4 separate sessions starting with baseline 1RM on 
bench, followed by a familiarization to exercise protocol. The familiarization and exercise 
protocol consisted of muscular endurance measured by 3 sets of repeated bench press to fatigue 
(failure) at 70 to 80% 1RM followed by three repeated Wingate tests (Forbes et al., 2007). The 
rest ratio was 1 to 2 minutes bench and Wingate respectively with 10 minutes between both 
measures.  
After both baseline testing and familiarization sessions participants returned for 2 more 
supplemental testing sessions. Participants arrived fasted (3 hours) and refrained from caffeine 
use for 48 hours (Forbes et al., 2007). The supplement, Redbull®, was compared to a 
noncaffeinated lemon citrus soft drink (noncaffeinated Mountain Dew®) ingested one hour prior 
to exercise testing (Forbes et al., 2007). Redbull® is an example of cocktail mixtures containing 
ingredients other than a pure caffeine dose. Forbes et al. (2007) used the caffeinated beverage 
Red Bull® is dosages to equate to 2.0 mg/kg of caffeine including: sugar 0.65 mg/kg, taurine 25 
mg/kg, Glucuronolactone 15 mg.kg, niacin 0.45 mg/kg, pantothenic acid 0.15 mg/kg, vitamin B6 
0.05 mg/kg, riboflavin 0.04 mg/kg, and vitamin B12 0.025 µg/kg. The protocol for testing was 
the same as the familiarization. There were no differences in caffeine groups (habitual versus 
naïve) and both groups were assessed together.  
The results found Redbull® increased total number of repetitions 34 ± 9, compared to 
placebo 32 ± 8 reaching significance (P = 0.031) (Forbes et al, 2007). There was no difference in 
Wingate performance peak power, or average power in Redbull® compared to placebo. The 
fingertip blood lactate (mmol/L) measures showed a time effect within group at baseline (P 
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<0.01), after set 1 (P <0.01), and set 1 to set 2 (P =0.016) (Forbes et al., 2007). No difference 
was observed after set 3 or 2 minute post measure. Group comparison found that 
supplementation significantly increase muscular endurance but did not affect Wingate measures 
(peak and average power) or blood lactate concentration (Forbes et al., 2007).   
All the cocktail mixtures contained niacin, pantothenic acid, and vitamin B6 (Beck et al., 
2006; Beck et al., 2008; Forbes et al., 2007) in addition to caffeine. The listed studies all 
examined performance markers of resistance training and capabilities of anaerobic exercise in 
comparison to placebo. The interrelation between these studies is that there was no isolation of 
ingredients. This suggests that an increase in 1RM bench (Beck et al., 2006) will not transfer to 
increased number of repetitions of bench in Forbes et al. (2007) because of ingredients that are 
unaccounted for.  
Ergogenic nutrition supplements released to consumers are not regulated routinely nor 
tested for safety or effectiveness by the Food and Drug Administration (FDA) (FDA, 2015). This 
lack of regulation of efficacy and safety is compounded by mixed ingredients of unknown 
quantities in cocktail supplements such as those investigated by Kedia et al. (2014); Smith et al. 
(2010); Spradley et al. (2012); and Outlaw et al. (2014). It is increasingly difficulty to investigate 
claims because companies generally do not disclose individual ingredient dosages. The 
predominate standard of investigation for claims for performance enhancement or ergogenic 
potential is to identify individual ingredients. Kedia et al. (2014) examined the safety and 
efficacy of pre-workout supplementation but noted that comparing individual ingredients of 
cocktail supplements is difficult in determining combined performance potential. Overall the 
acute effect of pre-workout supplements for ergogenic potential in anaerobic exercise is not well 
researched.  
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In the study by Spradley et al. (2012) investigators measured acute ergogenic potential of 
a pre-workout supplement (Assault™ by MusclePharm) to placebo but failed to compare it to 
individual ingredients including branched chain amino acids, caffeine and numerous other 
potentially performance-enhancing substances (Table 1). Research studies comparing both 
individual and combined ingredients in a pre-workout supplement could potentially test for a 
synergistic effect beyond consumption of individual substances. In another study, Hoffman et al. 
(2008) investigated the acute hormonal effects of a “pre-exercise energy supplement” but did not 
comprehensively compare the study dose to anaerobic exercise or ergogenic potential. This study 
did, however, effectively list the dose of each ingredient in the commercially available 
supplement (Amino Shooters™ by Champion Nutrition Inc.) (Hoffman et al., 2008, pg 878). 
This as previously noted is not a common occurrence in multi-ingredient “cocktail” supplements. 
Finally investigators Smith et al. (2014); and Kedia et al. (2014) researched and focused 
on exercise training studies. First Smith et al. (2014) experimentally tested 3 weeks of HIIT on a 
treadmill compared to Kedia et al. (2014) using 6 weeks of muscular strength training 
respectively using multiple doses of pre-workout supplements. Furthermore, Outlaw et al. (2014) 
used a four-day spilt training program for the duration of an eight-day study. This study did not 
account for adequate time after eight days of supplementation for participant recovery. Likewise 
with longer investigations, training studies mask the acute ergogenic potential of these pre-
workout supplements due to neuromuscular adaptation, recovery-time, and muscle hypertrophy 
(Katch et al., 2011). After reviewing each investigation, the results are applicable only to the 
specific cocktail mixture investigated as specific dosage, individual ingredients nor their 
individual affects are not known (Kedia et al., 2014; Smith et al., 2010; Spradley et al., 2012; and 
Outlaw et al., 2014). The report results of the acute effects for ergogenic potential are limited but 
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warrant further investigating. Also, cocktail mixtures may result in unwanted side effects as 
reported by Kedia et al. (2014) and Mahan et al. (2012).  This is an important consideration 
involved with choosing the correct supplement. 
Iron Pump™ is pre-workout supplement created by MusclePharm (Denver, Colorado). 
This supplement is marketed as having the ergogenic potential to affect vasodilation and is 
intended to increase blood flow to muscles during exercise (MusclePharm, 2013). This ergogenic 
supplement functions with the nutritional compound L-arginine nitrate, which is a salt 
combination of l-arginine and nitric acid and a precursor to nitric oxide (MusclePharm, 2013).  
The combined ingredients of this pre-workout supplement are similar to Assault ™ 
(MusclePharm Corp, 2013) investigated by Spradley et al. (2012) because both contain 
undefined energy blends produced by MusclePharm and both cocktail mixtures contain unknown 
doses of L-arginine. The breakdown of Iron Pump™ includes a combination of multiple 
ergogenic ingredients and two primary ingredients that may affect muscle activity and blood 
flow: L-arginine nitrate and caffeine as an energy blend including anhydrous caffeine (Spradley 
et al., 2012; MusclePharm, 2013).  
Although several researchers have attempted to pinpoint effects of specific ingredients 
within cocktail ergogenic mixtures, these studies have limited ability to generalize the ergogenic 
potential effects of individual ingredients. This is because researchers do not know the given 
amount (dosage) or they do not contain the same specific ingredients in each supplement. In 
comparison to the apparent lack of research regarding a similar supplement (to Iron Pump™) it 
may be more important to compare the individual ingredients of Iron Pump™ to ergogenic effects 
of those individual ingredients in scholarly work, in order to arrive at a possible ergogenic 
potential. Therefore, the next several sections break down individual Iron Pump™ ingredients 
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including L-arginine nitrate and caffeine, specifically related to ergogenic potential, safety and 
efficacy of anaerobic training (Astorino, & Roberson, 2010a) and blood flow. MusclePharm 
(2013) claims:  
“Iron Pump™ utilizes “Super Nitric Oxide” ION-3 Nitrate Technology to open up blood 
pathways into the muscles, improving the effectiveness of the ordinary molecule. As the world’s 
first molecularly-modified arginine, L-Arginine Nitrate is a fusion of l-arginine and nitric acid 
that increases blood flow to enhance distribution of nutrients.”  
Figure 1. A schematic diagram of the physiologic disposition of nitrate, nitrite, and nitric oxide 
from exogenous (dietary) and endogenous sources (Ivy, 2015). 
Nitric oxide, nitrate, nitrite, and L-arginine   
Iron Pump™ is promoted as an L-arginine nitrate supplement (MusclePharm, 2013). L-
arginine is a precursor to nitric oxide synthases, whereas, nitrate or nitrite are more immediate 
precursors to nitric oxide (Hord, Tang, & Bryan, 2009). The nitric oxide released by cells after 
synthesis or absorption of nitrate or nitrite, has a vasodilating effect that is localized in blood 
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vessels (Mahan et al., 2012). There are a number of exogenic and endogenic pathways for nitric 
oxide as illustrated in Figure 1. Search terms for citations found using supplements or exercise in 
association with L-arginine, nitric oxide, nitrate, nitrite, caffeine, and caffeinated.  
Further, the USDA Nutrient Database, the Food and Agriculture Organization (FAO), 
and World Health Organization (WHO) do not report any nitric oxide, nitrite, or nitrate (USDA, 
2015; FAO, 2015; WHO, 2015). There is more information available, about caffeine as an 
individual ingredient than L-arginine in research (Bescós, Sureda, Tur, & Pons, 2012). This 
compares to database search results including PubMed, Google Scholar, and ProQuest, caffeine 
as an individual supplement (≈ 94,000 hits) than L-arginine alone (≈ 33,000 hits).  
L-arginine is an essential amino acid that works to synthesize nitric oxide in cells (Hord 
et al., 2009; Mahan et al., 2012). Good dietary sources of nitric oxide include beets, beet root 
juice, kale, arugula, spinach, and Swiss chard. Therefore the supplement is intended to mimic 
this natural process illustrated in Figure 1. 
The supplementation of L-arginine, or nitric oxide, including cocktail mixtures has 
ergogenic potential to enhance endurance exercise through cardiorespiratory adaptation and 
increased tolerance to exercise (Bescós et al., 2012; Bailey et al., 2010; Camic et al., 2010a; 
Camic et al., 2010b). In a systematic review, Bescós et al. (2012) found the majority of research 
on L-arginine or nitric oxide to be based on endurance ergogenic potential (e.g. aerobic exercise 
to exhaustion) rather than resistance training (e.g. measured muscular strength, muscular 
endurance, and anaerobic capacity ~Wingate test). This warrants further investigations of nitric 
oxide and L-arginine related to resistance training. Another problem with L-arginine nitrate is 
that the ergogenic potential of the individual substance has yet to be established and have 
primarily shown results in cocktail mixtures (Bescós et al., 2012; Bailey et al., 2010; Camic et 
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al., 2010a; Camic et al., 2010b). The article by Bescós et al. (2012) identified the lack of research 
involving nitric oxide in isolation. Therefore, further research analyzing these compounds in a 
mixture and as individual ingredients is important to better understand the effects of combining 
cocktail supplements. However a single “dose” of beet-root juice costs approximately ≈ $15.00 
(USD) (Swanson Health Products, 2015). 
Furthermore Iron Pump™ does not disclose the amount of L-arginine nitrate nor the 
caffeine content of its energy blend per dose (1 Scoop) (MusclePharm, 2013). While the 
manufacturer claims that L-arginine nitrate is responsible for vasodilation, caffeine may also 
play a crucial role yet to be determined in the cocktail mixture (Bescós et al., 2012; Kedia et al., 
2014). For simplicity L-arginine, nitrite, nitrate and nitric oxide will be referred to as nitric oxide 
(NO). 
Caffeine use as ergogenic aid  
For the purpose of this study the aerobic effects of caffeine are positioned by 
Rosenbloom, & Coleman (2012): 
"The strongest evidence is that caffeine can enhance endurance performance.” 
This increased performance is likely related to the stimulation of the central nervous system and 
decreased rate of perceived effort (Rosenbloom et al., 2012). This position stand was established 
in accordance with American College of Sports Medicine ACSM (2009) related to sufficient 
evidence. However few studies have investigated the acute effect of caffeine with anaerobic 
exercises (Astorino et al., 2010a).  
 Strategic intake of caffeine has been documented since the early 1900s and has been 
rigorously studied for its ergogenic effects during exercise (Astorino et al., 2010a; Jacobson, & 
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Kulling, 1989). Although caffeine is naturally found in a variety of foods and drinks, it is often 
supplemented. The habitual use of caffeine as an ergogenic aid is more common than all others 
(Jacobson et al., 1989; Graham, 2001b), which could be attributed to its wide availability. The 
caffeine complex or 1, 3, 7-trimethylxanthine is readily absorbed in the small intestine within 45 
minutes (range, 15 to 120 minutes) after consumption (Higgins, & Babu, 2013; Magkos, & 
Kavouras, 2005). After ingestion caffeine has a reported half-life of up to 3 to 4 hours which can 
vary from 2 to 12 hours, which provides prolonged circulation of caffeine until excreted or 
otherwise, used (Graham, 2001a; Higgins et al., 2013; Magkos et al., 2005).  
 Caffeine has ergogenic potential both as an individual supplement and as a combined 
ingredient in a cocktail mixture, as explained previously (Beck et al., 2006; Beck et al,, 2008; 
Forbes et al., 2007; Kedia et al., 2014; Hoffman et al., 2008; Smith et al., 2010; Spradley et al., 
2012; Outlaw et al., 2014). The effect that caffeine has on enhancing aerobic performance in 
endurance exercises is well researched (Bell & McLellan, 2003; Davis, & Green, 2009). Bell et 
al. (2003) examined the effect of a repeated dose of caffeine during repeated maximal endurance 
exercise in recreational male cyclists (n=9, 33 ± 7 years). The study used a double-blinded, 
randomized design to examine four treatment protocols measuring VO2max, heart rate, blood 
lipids (free fatty acids), blood glucose, and blood caffeine concentration. All participants 
habitually used caffeine (≥ 300 mg·d-1) measured by a self-reported questionnaire.  
This study consisted of 7 total visits, starting with VO2max measured on an electrically 
brake cycle ergometer followed by two familiarization trials (no treatment). The two-day food 
diaries were collected before the familiarization trial in order to replicate that diet for all 
subsequent trials (Bell et al., 2003). The repeated exercise consisted of two sets of cycle 
ergometer testing per day separated by 5 hours (AM, PM) one day per week was examined 
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compared to placebo. Participants refrained from caffeine for 12 hours prior to each trial and 
ingested treatment (1, 2, 3, or 4) 1 hour prior to exercise and consumed a cereal bar 15 minutes 
post caffeine ingestion (Bell et al., 2003). There type of cereal bar including ingredients and 
calorie content was not discussed. The treatment protocols were as follows: treatment 1 =5 
mg/kg caffeine AM and 2.5 mg/kg PM, treatment 2 = placebo AM/PM, treatment 3 =5mg/kg 
AM and placebo PM, treatment 4 =5 mg/kg AM/PM (Bell et al., 2003). The cycle ergometer test 
used two phases: phase one was a 5 minute ride at 50% VO2max, the second phase was time to 
exhaustion (≈15 minutes) at 80% VO2max (Bell et al., 2003).  
The groups treated with caffeine significantly (P < 0.05) increased time to exhaustion 31 
± 18% compared to placebo (Bell et al., 2003). However treatment 1 and 3 did not show strong 
efficacy for improved performance with a second dose of caffeine in the PM trial. The caffeine 
supplement also decreased rate of perceived exertion (RPE, 14.7 ± 2.2) in 80% time to 
exhaustion ride compared to placebo (15.6 ±   2.3) (Bell et al., 2003). Furthermore group 
differences of lactate concentrations were significantly higher (P < 0.05) with caffeine ingestion 
(6.87 ± 1.59) compared to placebo (6.30 ± 1.60). Caffeine did not have any effect on free fatty 
acids but increased glucose concentrations. This observation is expected during the physiologic 
stress of exercise on the body. This investigation suggests that there is a strong correlation 
between caffeine intake and RPE during aerobic performance (Bell et al., 2003). Therefore this 
study illustrates caffeine has an ergogenic effect of aerobic performance. 
Caffeine use in study populations 
 Published caffeine related research studies include various doses of caffeine investigating 
as low as 2 mg/kg to as high as 9 mg/kg (Graham, 2001a). The National Collegiate Athletic 
Association (NCAA) restricts the use of caffeine at doses ≥ 9 mg/kg, because doses this high 
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have the possibility of a positive doping test at a urine concentration > 15 µg·ml-1 (ACSM, 
2009). Many studies have tested only one dose of caffeine relating to anaerobic performance 
measures, while some used various levels of doses within anaerobic testing (Astorino, Terzi, 
Roberson, & Burnett, 2010b; Beaven et al., 2008; Jacobson & Thurman-Lacey, 1992a; Jacobson 
& Edwards, 1991).  
 Astorino et al. (2010b) examined caffeine intake and the isokinetic potential of exercise 
in recreational active males (n=15, 26.4 ± 3.9 years). This investigation used a single-blinded 
crossover design with counterbalance. Astorino et al. (2010b) counterbalance ensured that no 
participants knew the order of treatment as well all supplements were prepared by the same co-
investigator. Participants were screened for caffeine intake and required >100 mg·d-1 of habitual 
use (Astorino et al., 2010b). There was no maximum caffeine intake or methods of measurement 
for habitual caffeine use. Further, participants were required to be nonsmokers and recreationally 
active for four hours per week. Astorino et al. (2010b) investigated two separate dosage of 
anhydrous caffeine (2 and 5 mg/kg) compared to placebo (lemon-flavored noncaloric beverage, 
Crystal Light, Northfield, IL). Isokinetic strength potential was measured using knee extension 
and flexion of the dominant leg in a seated dynamometer (Biodex System 4; Biodex, Shirley, 
NY) (Astorino et al., 2010b). The Biodex System 4 was used to measure peak and average 
torque, power, total work, and work fatigue. Astorino et al. (2010b) revealed through pilot 
testing that the coefficient variance for extension; peak torque (5.3%), total work (7.8%) and 
peak flexion torque (6.5%).  
A total of four trials were conducted first beginning with a familiarization trial 1 set of 40 
repetitions on the Biodex. Additionally researchers recorded participant individualized seat 
measurements including seat angle, chair location, lever arm length, and isokinetic attachment 
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during familiarization for subsequent trials (Astorino et al., 2010b). Participants were required to 
refrain from caffeine for 48 hours prior to each trial. During supplementation, the same assistant 
mixed one of the three total samples for each participant and likewise that supplement was 
ingested 1 hour prior to exercise (Astorino et al., 2010b). The exercise protocol incorporated 2 
maximal sets at 40 repetitions knee flexion/extension (1 flexion + 1 extension = 1 repetition) 
(Astorino et al., 2010b). The result revealed a significant decrease between set 1 and 2 for peak 
torque extension and flexion (P < 0.05) with intergroup comparison (3x2, ANOVA, repeated 
measure) (Astorino et al., 2010b). The decline between set 1 and 2 was consistent for all 
measures including average torque, total work, and power output (P < 0.05). However peak knee 
flexion reached significance in set 1 (P < 0.05, F (2,28) = 4.24) in 5 mg/kg supplement compared 
to placebo (Astorino et al., 2010b). The same result effect (P < 0.05) was found for total work in 
both knee extension, 5 mg/kg compared to placebo and 2 mg/kg in set 1; and knee flexion, 5 
mg/kg compared to placebo only in set 1 (Astorino et al., 2010b).  
Beaven et al. (2008) investigated the acute effect of caffeine related to hormonal response 
during exercise in professional male rugby players (n=24, 22.3 ± 3.0 years). The study was 
double-blinded and consisted of 4 randomized trials (Beaven et al., 2008). Participants 
completed a 24-hour food recall to assess caffeine intake and were asked to refrain from 
ingesting dietary caffeine before trials, no washout period. This investigation used four definitive 
but separate doses of caffeine 200 mg, 400 mg, 800 mg, and 0 mg (placebo) ingested 1 hour 
prior to exercise (Beaven et al., 2008). The resistance training portion of this study was based 
around a rugby practice including back squat, deadlift, lunge, and sprinting.  This study did not 
directly propose to measure ergogenic potential of exercise other than focusing on effects of 
resistance exercise and hormonal concentrations. These concentrations were measured with 
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salivary samples (2ml) collected at dosing, immediately before exercise, every 15 minutes during 
exercise, and at 15- and 30 minutes post-exercise (Beaven et al., 2008). The salivary samples 
could have been contaminated if participants consumed hot beverages or brushed their teeth 
within 2 hours of each trial (Beaven et al., 2008). Although athletic performance was not directly 
measured there were improvements within caffeine dose. The larger dose of caffeine (800 mg) 
showed a relationship with decreasing sprint times during practice (1.7%; 90% confidence limits 
± 2.5) (Beaven et al., 2008). Additionally, the salivary samples revealed an increase in 
testosterone concentration (15% ± 19%) with ≥400 mg of caffeine (Beaven et al., 2008). 
Similarly salivary cortisol increased with doses of caffeine ≥400 mg with 800 mg 51% increase 
(±41%) dose-response. This study suggests a dose-response relationship between caffeine 
supplementation and both cortisol and testosterone concentration during exercise.   
 An early experiment by Jacobson and Thurman-Lacey, (1992a) included female 
participants (n=40, 21 ± 1.7 years) the effect of two doses of caffeine on manipulative skills. 
Fitness level of the participants was not discussed other than using a college student sample. This 
sample included 20 habitual caffeine (caffeine familiar) users identified by caffeine intake > 750 
mg·d-1, and 20 naïve or caffeine intake < 90 mg·d-1. This study used a double-blinded crossover 
design with a 5-day caffeine questionnaire to recall caffeine use in determining habitual versus 
naïve caffeine users. The purpose of this investigation was to examine the physiological effects 
on the body measured by steadiness, dexterity, and tracing ability (Jacobson et al., 1992a). Prior 
to the investigation caffeine naïve subjects abstained from caffeine for 4 days whereas habitual 
caffeine users maintained normal caffeine intake (Jacobson et al., 1992a). The doses of caffeine 
used within this study 2.5 and 5 mg/kg compared to placebo were intakes were randomized and 
ingested 1 hour prior to testing. The results show significant differences (p <0.05) in 
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physiological effects of caffeine on dexterity and hand steadiness within naïve caffeine users but 
not within caffeine familiar (habitual caffeine users) group (Jacobson et al., 1992a). Specifically, 
results were altered between the 5 mg/kg and both 2.5 mg.kg or placebo within sample 
comparison. No significant differences existed between dose and habitual caffeine users because 
confounding factors such as high caffeine intake (> 750 mg·d-1) or the lack of constraints for 
participants to refrain from caffeine prior to testing.  
Jacobson & Edwards, (1991) examined the effect of two doses of caffeine on peak torque 
and muscular endurance in male and female participants (n=20, n=16 respectively) (n=36, 20.5 
years mean no SD). All participants reported a habitual caffeine intake >200 mg·d-1 and screened 
(questionnaire) for excess caffeine use (Jacobson et al., 1991). This study used a double-blinded 
randomized trial with three treatments: 600 mg, 300 mg, and placebo. The participants refrained 
from caffeine for 24 hours and ingested supplement 1 hour prior to testing (Jacobson et al., 
1991). The exercise protocol included peak torque and muscular endurance for both knee flexion 
and knee extension. Furthermore three isokinetic velocities were measured and recorded using a 
Cybex II Isokinetic Dynamometer at 75 º/s (3 reps, 5 min rest), 180 º/s (3 reps, 5 min rest), and 
300º/s (15 reps, 10 min rest) (Jacobson et al., 1991). The results of the habitual caffeine use 
questionnaire revealed ≈89.4 and 109.2 mg·wk-1 (Jacobson et al., 1991). There was an increase in 
combined torque and velocity within both 600 mg and 300 mg treatments however the response 
did not reach significance (p >0.05) (Jacobson et al., 1991). This suggests that caffeine does not 
affect ergogenic potential in relation to maximal strength.  
 The studies that used multiple doses of caffeine found a mixture of results, depending 
upon the dose. While Jacobson et al. (1992a) found a statistical significance of motor 
performance measured by hand steadiness and tracing “drawing” tasks among caffeine naïve 
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subjects, no significance was discovered within habitual caffeine users. Although ergogenic 
potential was not examined in this investigation this research identifies possible differences in 
response to caffeine in habitual and naïve participants. Both Bell et al. (2003) and Jacobson et al. 
(1992a) used similar dosing procedures of a placebo, 2.5 mg/kg, and 5 mg/kg of caffeine. It was 
discovered that a repeat dose of caffeine 5 mg/kg in the morning and 2.5 mg/kg, 5 hours later did 
not reveal significance compared to a single dose of caffeine (5 mg/kg) and placebo (Bell et al., 
2003). However the dose of caffeine significantly increased time to exhaustion in both caffeine 
trials versus placebo trial, therefore it is suggested that one dose of caffeine is sufficient to 
maintain ergogenic potential. Although Bell et al. (2003) was an aerobic investigation the dose 
relationship and caffeine treatment directly related to Jacobson et al. (1992a). Therefore Bell et 
al. (2003) is excluded from further discussion beyond this point.  
 In a similar design Astorino et al. (2010b) examined two separate doses of caffeine intake 
and effect on muscular endurance measured with Biodex System 4. The significance of this 
study was that it measured unilateral isokinetic knee extension and flexion in the dominant leg 
(Astorino et al., 2010b). The dominant leg is determined by reaction and strength difference 
which is common among athletes. This study was unique in that supplementation was non-
controlled, referring to no visual consumption of caffeine supplement because supplements were 
provided to participants during familiarization trial (e.g. three bottled, sealed supplements). The 
participants were instructed to consume one supplement 1 hour before testing and return the 
empty container to researchers (Astorino et al., 2010b). The results of this study did not show 
efficacy (did not reach significance) for caffeine use < 5 mg/kg to be ergogenic potential. This 
suggests that a dose ≈ 2 mg/kg is not ergogenic in habitual caffeine users during isokinetic knee 
flexion and extension.  
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  Beaven et al. (2008) used set doses of caffeine rather than weight measured doses 
(mg/kg). This investigation revealed a possible beneficial effect related to an increase in 
testosterone response to exercise with doses ≥ 400 mg of caffeine (Beaven et al., 2008). The 
results for the most part were inconclusive for acute hormonal affect after ingesting caffeine. 
These investigations did not find a strong efficacy for examining more than a single dose of 
caffeine per activity or period of exercise for ergogenic potential other than possible effects 
between habitual and naïve caffeine users. In addition, this premise illustrates a possible reaction 
to caffeine in trained versus untrained participants. Overall research suggests that multiple dose 
studies are unnecessary as there is not a minimum recommended dose of caffeine for increased 
ergogenic potential. Therefore investigations should focus on single doses in relation to 
ergogenic potential.   
 The previous research used of multiple doses caffeine in their investigations however 
there was no strong efficacy found within that design. The following investigations are focused 
on single doses of caffeine and the dose-response relationship of anaerobic exercise (Anselme, 
Collomp, Mercier, Ahmaidi, & Prefaut, 1992; Astorino, Firth, &, Rohnmann, 2008; Beaven et 
al., 2008; Beck et al., 2006; Beck et al., 2008; Forbes et al., 2007; Hudson, Green, Bishop, & 
Richardson, 2008; Jacobs, Pasternak, & Bell, 2003; Kalmar et al., 1999; Timmins, & Saunders, 
2014). The minimum effective dose of caffeine has not been established for ergogenic potential 
within resistance training, but research shows improvements in ergogenic potential of all 
anaerobic athletic performance (resistance training, Wingate, sprint) with doses from 2.5 mg/kg 
to 7 mg/kg (Astorino et al., 2010a).  
Anselme et al. (1992) investigated caffeine supplementation in association with maximal 
anaerobic potential in recreationally active males (n=10) and females (n=4). Participants (n=14, 
 
 
29 
 
26 ± 1.72 years) were required to accumulate ≈ 3.5 hour per week of physical activity related to 
recreational sports. This investigation was double-blinded and randomized comparing 250 mg 
caffeine to placebo ingested 30 minutes prior to exercise (Anselme et al., 1992). The habitual use 
of caffeine was not measured or controlled throughout the study. Researchers measured blood 
lactate with intravenous samples during peak cycle ergometer sprints (Anselme et al., 1992). 
Blood samples were collected during rest/recovery of each load. The sprint protocol consisted of 
a maximum duration of 6 seconds starting with 2 kilograms of weight load on the cycle. After 
each set participants would recover for 5 minutes before the next sprint increasing by 2 kg, 1 kg, 
and 0.5 kg until maximum velocity was reached (Anselme et al., 1992). The peak load was the 
same for both treatments but the pedaling frequency of the caffeine group significantly increased 
(P <0.001) compared to placebo Anselme et al., 1992). Moreover, blood lactate reached 
significance in the peak load (8 kg) in caffeine group (P <0.01) and 5 minutes post recovery (P 
<0.04) to placebo comparison Anselme et al., 1992). This investigation suggests a positive 
relationship between peak anaerobic capacity and caffeine supplementation including increased 
levels of blood lactate.   
Astorino et al., 2008 used a double-blinded crossover method to investigate the acute 
effect of caffeine on anaerobic exercise. Researchers recruited resistance trained males (n=21, 
23.4 ±3.6 years) screened for habitual caffeine use. The method of screen for caffeine intake was 
not discussed however 4 participants reported being naïve users of caffeine (≈ 0 mg·d-1). 
Participants were required to refrain from caffeine for 48 hours pre-trial. The treatment 6 mg/kg 
of caffeine or placebo was ingested 1 hour pre-exercise (Astorino et al., 2008). During each trial 
researchers collected heart rate (HR) and blood pressure (BP) and measured anaerobic capacity 
with a 1RM test and repetitions to failure (fatigue) for both standard bench press and seated leg 
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press Astorino et al., 2008). The exercise protocol incorporated a 12-15 repetition warm prior to 
1RM determined within 3-6 sets and maximum weight lifted one complete rep (Astorino et al., 
2008). The repetitions to failure or muscular endurance was the total number of repetitions (to 
failure) at 60% 1RM. Astorino et al. (2008) reported side effects of caffeine supplementation 
similar to Kedia et al. (2014) with the addition of tremors, higher energy, and elevated heart rate. 
The results showed increased in weight lifted for both bench press and leg press but failed to 
reach significance (P >0.05). For example, twelve participants increased bench press (≥3 kg) 
with caffeine but five participants increased bench (≥3 kg) with placebo (Astorino et al., 2008). 
Likewise both bench and leg press muscular endurance increased total number of repetitions and 
total load but did not reach significance (P >0.05) (Table 3). Overall both HR and BP 
significantly increased with caffeine consumption (P <0.05) in naïve participants during warm-
up. The dose of caffeine and results from this study suggest a response-relationship of increased 
side effects in caffeine naïve participants. 
 Hudson et al. (2008) investigated the independent effects of caffeine and aspirin in 
combination with light intensity resistance trained (RT) in resistance trained males (n=15, 22 ± 
1.3 years, >8 weeks of training experience). All participants maintained RT 2-4 days per week 
and caffeine intake throughout the study, except within 24 hours of each trial (Hudson et al., 
2008). 
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This study used a double-blinded within subject design to measure the associated effects 
on muscular endurance, HR, RPE, and pain perception index (PPI). The participants reported 
habitual caffeine use ≈100-400 mg·d-1 the measurement used was not reported. The exercise 
protocol consisted of 3 treatment trials testing seated leg extension and seated arm curl (4 sets for 
12 repetitions) (Hudson et al., 2008). The twelve repetition sets were participant estimated 
repetition maximums counter-balanced for reps/set <11 or >13 was adjusted with increased or 
decreased weight (Hudson et al., 2008). The rest ratio was 3minute between sets and 5 minutes 
between exercises. The participants ingested caffeine (6-6.4 mg/kg), aspirin (10-10.4 mg/kg) or 
placebo 1 hour pre-exercise. The non-exercise measures (HR, PPI, and RPE) were measured at 
rest, pre-set, immediately post-set (within 10s) and 5 minutes post exercise. In addition 
Table 3  
Astorino et al. (2008) effect of caffeine on anaerobic performance 
Parameter Caffeine Placebo 
1-RM bench press (kg) 116.4 ± 23.6 114.9 ± 22.8 
Repetitions at 60% 1-RM (kg) 19.9 ± 4.3 18.4 ± 4.0 
Weight at 60% 1-RM (kg) 69.9 ± 14.3 68.9 ± 13.3 
Total weight lifted (kg) 1369.7 ± 383.1 1226.2 ± 357.3 
1-RM leg press (kg) 410.6 ± 92.4 394.8 ± 95.4 
Repetitions at 60% 1-RM 
(reps) 
23.9 ± 13.0 22.5 ± 11.0 
Weight at 60% 1-RM (kg) 247.9 ± 57.5 238.6 ± 55.5 
Total weight lifted (kg) 5945.9 ± 3275.6 5358.0 ± 2148.5 
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researchers used a questionnaire to measure symptoms related to supplement intake and possible 
side effects post-exercise (Hudson et al., 2008).  
The results of this study revealed a significant (p <0.05) increase in leg extension total 
repetitions within the caffeine group compared to across group samples. Additionally, a dose of 
caffeine significantly (p <0.05) increased HR in leg extension greater than aspirin and placebo 
(Hudson et al., 2008). However aspirin significantly (p <0.05) increased the RPE over caffeine 
supplementation. Inversely caffeine did not result in significant (p =0.051) increase in arm curl 
repetitions but significantly (p <0.05) increased HR compared to aspirin and placebo (Hudson et 
al., 2008). Furthermore post-exercise questionnaire resulted in significant (p <0.05) increased 
reports of side effects with caffeine ingestion only (Hudson et al., 2008). The side effects 
reported were similar to those previously reported (Astorino et al., 2010a; Kedia et al., 2014) and 
included restlessness, tremors, and stomach distress (Hudson et al., 2014). Overall the results of 
this study suggest a dose response reaction to caffeine consumption and HR variability. Further a 
dose of aspirin has shown a greater anti-algesia effect than caffeine.   
Jacobs et al. (2003) investigated the independent and combined effect of caffeine 
ephedrine on muscular endurance in recreational active males (n=13, 18-34 years of age). This 
study used a double blinded, repeated measures. The researchers used the a priori analysis in 
order to estimate the number of participants required with a statistical power of 0.8 and 
expectation that treatment would cause 30% difference in repetitions performed during one set of 
exercise (Jacobs et al., 2003). The dietary intake of caffeine was not controlled nor measured 
except that participants did not avoid caffeine. This study required participants to attend 9 
sessions that began with an initial visit to measure 1RM for leg press and bench press was 
measured followed by 2 succeeding familiarization trials to adapt participants to fasting but 
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euhydrated state. Participants were given a standardized breakfast with choice of white toast, 
muffin, or bagel and the choice of apple or orange juice all subsequent trials used the same meal. 
Participants’ refrained from caffeine, alcohol, and medication 48 hours pre-exercise sessions (4-
8) all participant trials were randomized (Jacobs et al., 2003).  
Trials tested one of four treatments including caffeine (4 mg/kg), ephedrine (0.8 mg/kg), 
both caffeine and ephedrine combined or placebo, each treatment was ingested 90 minutes prior 
to exercise. The exercise protocol consisted of a warm up of 10 reps at ≈30%, and 3 supersets, 
supine/seated leg press at 80% 1RM to failure, followed by bench press at 70% 1RM to failure 
(Jacobs et al., 2003). The superset was defined as one leg set to one bench set to failure without 
rest (Jacobs et al., 2003). Each superset was then followed by 2 minutes of rest. The exercise 
measures were recorded as total work calculated from total number of repetitions and total 
weight lifted. The non-exercise measurements included BP, HR, blood hemodynamics 
specifically concentrations of caffeine and ephedrine analyzed by mass spectrometry (GC-MS) 
(Jacobs et al., 2003). The data was analyzed by a repeated factorial measure (2 X 2 X 3) 
ANOVA determining effects of caffeine (present or absent) an ephedrine (present or absent) 
and set (1, 2, or 3) (Jacobs et al., 2003).  
The consumption of caffeine increased the total number of repetitions (13.6 ± 6.5) but did 
not reach significance (P <0.05) compared to placebo (12.5 ± 5.0, set 1) (Jacobs et al., 2003). 
The combination of caffeine and ephedrine significantly (P<0.05) increased the number of 
repetitions for leg press (18.5± 8.4) and bench press (14.3 ± 3.1) compared to caffeine and 
placebo (set 1) (Jacobs et al., 2003). However this study revealed a hypertensive reaction to the 
combination treatment (caffeine and ephedrine) resulting in participants (n=2) BP to increase to 
204/ 90 and 214/112 pre-exercise 90 minutes post consumption (Jacobs et al., 2003). This 
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relationship demonstrates evidence of a synergistic effect of nutritional supplements. There was 
no statistical effect after set 1 in any treatment. The results reflecting ephedrine are not 
considered relevant to caffeine as ephedrine is a banned substance FDA (FDA, 2015). 
Kalmar et al. (1999) investigated the effects of caffeine on neuromuscular function in 
healthy males (n=11, 22.3 ± 2.4 years). This study used a double blind repeated measure with a 
caffeine dose of 6 mg/kg compared to placebo (Kalmar et al., 1999). The activity level of 
participants was not discussed nor was the inclusion criteria other than habitual caffeine use. 
Participants self-reported caffeine intake ≤ 200 mg·wk-1; in addition, they were required to 
abstain from caffeine for seven days before and throughout the study. The researchers did not 
report the measurement tool used to assess caffeine intake. The blinding procedures used a coded 
envelopes system that was identified by the participant’s initials and the day the dose was used 
(Kalmar et al., 1999). Each trial consisted of a randomized treatment and each treatment was 
separated by three days. Caffeine was administered and ingested one hour pre-exercise. The 
exercise protocol consisted of four parts including 1) tibialis nerve stimulation of the left soleus 
10 times lasting 1-ms, 2) maximal voluntary contraction (MVC) of the right knee extensors 4 
repetitions, 3) 6 submaximal contractions, and 4) 50% MVC held to failure (Kalmar et al., 1999). 
The results found MVC (Part 2) reached significance (P <0.01) with an increase of 3.5 ± 1.01% 
in caffeine compared to placebo (Kalmar et al., 1999). There was no significant effect in reflex 
of the soleus as well as submaximal contractions with caffeine consumption. Caffeine, however 
resulted in a significant increase (P <0.05) the time to failure at 50% MVC (Kalmar et al., 1999). 
This suggests that caffeine may increase maximal contraction and beneficially effect sustained 
muscle activation. 
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Timmins et al. (2014) examines the effect of caffeine on MVC in resistance trained males 
(n=16, 21.1 ±0.8 years). This study used a single blind cross over randomized trial with a 6 
mg/kg caffeine dose compared to placebo with both upper and lower segments (Timmins et al., 
2014). Participants completed a habitual caffeine use questionnaire which identifying 
participants ≤ 300 mg·d-1 (Timmins et al., 2014). Participants were excluded if they had <1year 
RT experience or if they used nicotine or any other tobacco product. The researchers first of 
three sessions included a participant familiarization to the exercise protocol.  
The exercise protocol measured the isokinetic peek torque of knee extensors, ankle 
plantar flexors, elbow flexors and wrist flexors in the subsequent trials (Timmins et al., 2014). 
Each exercise was measured at an angular velocity of 60 º/s with 3 repeated 1RM. Participants 
were asked to refrain from caffeine for 24 hours pre-exercise with a single week separation 
between treatment (Timmins et al., 2014). Thirty minutes after ingesting the respective treatment 
participants started MVC using the isokinetic dynamometer Biodex System 3 Pro (Biodex 
Medical Systems, Shirley, NY).  
The caffeine frequency questionnaire revealed participants consumed ~95.4± 80.0 mg·d-1 
(Timmins et al., 2014). Further results revealed a significant difference (p<0.001) in peak 
isokinetic torque between muscle groups (upper/lower) (Timmins et al., 2014). There was also a 
significant increase (p =0.011) in peak torque from placebo to caffeine. The total effect of 
caffeine increased knee extension 13.7% (237.0 ± 69.5) compared to placebo (208.4 ± 38.3) 
(Timmins et al., 2014). The results found within this research support caffeine supplementation 
for ergogenic potential on peak isokinetic torque.  
The analysis of select caffeine related anaerobic studies that used a single dose can be 
divided into two groups; 1) caffeine ingestion ≥ 4 mg/kg, and 2) < 4 mg/kg. The first group 
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(Astorino et al., 2008; Hudson et al., 2008; Jacobs et al., 2003; Kalmar et al., 1999; Timmins et 
al., 2014) are studies that used caffeine ≥ 4 mg/kg (or equal about or greater than 300 mg) of 
caffeine ingested and the second group (Anselme et al., 1992; Beaven et al., 2008; Beck et al., 
2006; Beck et al., 2008; Forbes et al., 2007) researched dosage < 4 mg/kg (or less than about 300 
mg) of caffeine ingested. 
 In addition, most studies used a randomized, double-blind controlled design and included 
a 24-hour period (minimum period) non-controlled to withdraw caffeine from dietary 
consumption (Astorino et al., 2010a). However a review by Graham (2001a) found that 
exclusion periods from caffeine whether there was no withdrawal, 24 hours, or 4 days shows no 
difference in exercise performance. This suggests that depending of the level of habitual caffeine 
intake, withdrawal periods may not differ beyond 12 to 48 hours. Conversely this withdrawal 
period when greater than 48 hours may increase participants’ sensitivity to caffeine, causing 
intoxication when consuming high doses (Graham 2001a). Much of the research recommends a 
12 to 48-hour abstinence period to remove caffeine and re-sensitize the body (Astorino et al., 
2010a; Astorino et al., 2008; Astorino et al., 2010b; Forbes et al., 2007; Hudson et al., 2008; 
Jacobs et al., 2003). One research team had participants “rinse” from caffeine-containing 
beverages for 7 days and throughout the study (Kalmar et al., 1999). “Cleansing is the 
withdrawal, or re-sensitizing are periods of time without caffeine. These are common in most 
research where the use of habitual caffeine users versus non-caffeine users (naïve) has presented 
another possible shape for research design.  
Another experiment by Tarnopolsky and Cupido (2000) supported the use of habitual 
(n=6, 29 ± 7 years) and naïve (n=6, 26 ± 4 years) caffeine users within physically active males 
(n=12, ≥3 workout day·wk-1). This study was double-blinded, crossover, and counter-balanced 
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design. The caffeine intake >500 mg·day-1 (actual ≈771 ± 295, mg) was deemed as habitual use 
(Tarnopolsky et al., 2000). Whereas naïve or noncaffeine users intake <50 mg·day-1 (actual ≈14 
± 17, mg) (Tarnopolsky et al., 2000).  The participants completed self-reported food frequency 
questionnaires (FFQ) to estimate caffeine, and caloric intake with a computer program 
(Nutritionist IV, Silverton, OR). The experimental protocol used randomized (right or left) leg 
muscle stimulation to fatigue (failure) at one of two electrical hertz (Hz) (20Hz twice, and 40Hz) 
which measured the peak twitch torque and tetanic torque of the dorsiflexor muscle 
(Tarnopolsky et al., 2000). This protocol was then measured with one of two randomized 
treatments: 1) caffeine dose (6 mg/kg) or 2) placebo (Tarnopolsky et al., 2000).  Participants 
refrained from caffeine for 12 hours prior to each investigation and began exercise 90 minutes 
after ingestion. The results found within this study was that there were no effects of interactions 
between habitual and naïve caffeine users (Tarnopolosky et al., 2000). The related caffeine 
groups were assessed together in an across group comparison. There was a significant increase 
(P <0.005) in tetanic torque with caffeine supplementation and 20Hz stimulant compared to 
placebo (Tarnopolsky et al., 2000). However the 40Hz stimulant did not reveal any significant 
difference between groups. This study suggests that caffeine may directly and ergogenic effect of 
muscle.    
Similarly Forbes et al. (2007) and Astorino et al. (2008) classified users as caffeine naïve 
with intake <100 mg·day-1 and ≈ 0 mg·day-1 respectively which is consistent with the measure 
used by Tarnopolsky et al. (2000). A concurrent finding within Tarnopolsky et al. (2000), Forbes 
et al. (2007) and Astorino et al. (2008) was that there were no differences in measured torque, 
Wingate/muscular endurance, or 1RM/muscular endurance respectively between habitual and 
naïve users. The only difference was that naïve users experienced more pronounced symptoms 
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such as: tremors, insomnia, greater energy, elevated heart rate, headache, stomach distress 
(upset), and restlessness associated with caffeine intake (Astorino et al., 2008; Hudson et al., 
2014; Kedia et al., 2014).   
In another perspective Jacobs et al. (2003) did not control or make an effort to estimate 
caffeine intake in participants prior to participation and asked participants to not consume coffee 
48 hours prior to testing. This was despite caffeine content of other substances. Most studies 
identified participants either as habitual users or nonhabitual (naïve) users by measuring caffeine 
intake with the exception of previously listed research examples. Furthermore those studies that 
identified habitual caffeine intake also used withdrawal periods for caffeine ranging from 0 to 4 
days. Overall the listed studies have not effectively or concisely determined the ergogenic effect 
of caffeine. The major impact of including nonhabitual (naïve) users is that the side effects are 
more apparent than those that regularly use caffeine (habitual users).     
Furthermore gender which has lead research direction annotated by Graham (2001b) 
revealed no difference in caffeine clearance after 90 minutes of exercise related to gender in 
studies that used females that were not on oral contraceptives. On the contrary evidence suggests 
that female participants using daily contraceptives have a decreased clearance (removal from the 
body) of caffeine (Abernethy & Todd. 1985) and that the luteal phase (latter stage) of the 
menstrual cycle also impairs caffeine degradation (breakdown and clearance) (Lane, Steege, 
Rupp, & Kuhn, 1992). This evidence was cited as exclusion criteria for participants in Kalmar 
and Cafarelli (1999); Astorino et al. 2008; Hudson et al. 2008; whereas some studies did not 
account for this information and investigated both male and female participants (Forbes et al., 
2007). Others justified the exclusion of female participants by other means such as unknown 
effects on a potential fetus with a combination of caffeine and ephedrine (Jacobs et al., 2003). 
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Research by Jacobson et al. (1992a) included a total female cohort, disregarding research 
related to females using oral contraceptives. This study did not investigate ergogenic potential 
but found differences within naïve compared to habitual caffeine users. Another study, 
Kamimori, Jubert, Otterstetter, Santaromana, and Eddington (1999) found evidence to refute 
decreased clearance related to the luteal phase of the menstrual cycle as suggested earlier (Lane 
et al., 1992). Gender differences are not fully understood and may not affect the outcome of 
research.   
Caffeine side effects 
Bunsawat, White, Kappus, and Baynard (2014) investigated pre-exercise caffeine 
consumption and autonomic recovery related side effects in healthy participants (n=18, 26 ± 1 
years, male n=10, female n=8). This study used a double-blinded crossover design measuring 
HR, heart rate variability HRV, heart rate recovery HRR, and VO2max with a maximal treadmill 
test (Bunsawat et al., 2014). Heart rate variability was collected with a continuous 5 minute ECG 
at a sample rate of 1000Hz (Biopac Systems, Santa Barbara, CA) (Bunsawat et al., 2014). This 
measure detected the rate and variance at which a heart muscle contraction occurred. There were 
two randomized treatments of caffeine (400 mg) and placebo ingested 45 minute pre-exercise. 
Participants who reported ≤285 mg·d-1 and were required to refrain from caffeine for 12 hours 
prior to exercise. The results revealed that caffeine significantly increased (p <0.05) HR max 
(192 ± 2) compared to placebo (190 ± 2) (Bunsawat et al., 2014). Caffeine, as expected 
significantly increased (p <0.05) time to exhaustion (13.3 ± 0.7) compared to placebo (12.8 ± 
0.7) (Bunsawat et al., 2014). The HRV increased in both treatment groups (p <0.05) but caffeine 
ingestion resulted in less variance post-exercise. Overall this study suggests that caffeine effects 
BP with delayed recovery post-exercise. The researchers’ related effect on autonomic recovery 
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to detrimental cardiovascular results including sudden death (Bunsawat et al., 2014). This is 
increasingly important to investigate as the use of caffeine during exercise is a growing trend.   
The side effects of excess caffeine consumption or intoxication have been discussed 
within ACSM (2009), Astorino et al. (2008), Bunsawat et al. (2014), Hudson et al. (2014), Kedia 
et al. (2014) and Tarnopolsky et al. (2000). These side effects include: anxiety, nervousness, 
rapid heartbeat, insomnia, jitteriness, gastrointestinal distress.  
Caffeine and tobacco use 
 Caffeine has several interactions with chemicals that affect clearance either increasing or 
decreasing half-life. Parsons and Neims (1978) reported that tobacco or specifically nicotine, was 
found to increase the clearance of caffeine, decreasing half-life. A follow-up investigation by 
Benowitz, Peng, and Jacob (2003) reached significance (P <.001) for oral clearance or decreased 
half-life in smokers compared to nonsmokers.  This research suggested that smoking does not 
increase urinary secretion of caffeine related to unaffected urine concentration of caffeine in 
smoking participants. This implication is important to consider in regard to controls within 
research design. 
Caffeine and blood flow 
Caffeine, as a supplement can have a positive effect on performance of anaerobic 
activities; caffeine can affect blood flow, increase blood pressure, and increases heart rate 
(Daniels, Mole, & Shaffrath, 1998; Shechter et al., 2011; Bell et al., 2003; Bunsawat et al., 
2014). In a study by Daniels et al. (1998) the research team investigated the effects of caffeine on 
blood measures during rest and during exercise in trained cyclists (n=10, 30 ± 0.3). The 
participants included males (n=3) and females (n=7) that were nonhabitual caffeine users (<100 
mg·d-1) (Daniels et al., 1999). The measures used in this study were, heart rate, blood pressure, 
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calculated mean atrial pressure (MAP), forearm blood flow (FBF), forearm vascular conductance 
(FVC) and angiotensin II (vasoconstrictor) (Daniels et al., 1998). FBF was measured using a 
strain gauge via venous occlusion plethysmography (Daniels et al., 1999). Participants were 
required to abstain from caffeine 4 days prior to testing and arrived 12 hours fasted (between 
6AM and 10AM) (Daniels et al., 1999). There was no discussion on time of arrival. This could 
possibly ease the strain of being fasted during exercise. The exercise protocol consisted a 55 
minute cycle ergometer trial at 65% VO2max. The trials were randomized into two treatment 
groups, caffeine (6 mg/kg) or placebo both ingested 45 minutes pre-exercise.  There were no 
statistical differences between males and females therefore they were assessed together. The 
results revealed a significant increase (P <0.05) in MAP 40 minutes post-caffeine consumption, 
likewise both systolic and diastolic BP increased 20 and 40 minutes respectively compared to 
placebo (Daniels et al., 1999). In addition, caffeine significantly increased (P <0.05) FBF and 
FVC after ingestion during exercise only compared to placebo (Daniels et al., 1999). Therefore 
this study suggests caffeine may positively affect angiotensin II, increasing vasoconstriction and 
blood flow during exercise. 
Shechter et al. (2011) examined the acute effect of caffeine on brachial flow-mediated 
dilation (FMD). This study used a double-blinded, crossover design in participants with and 
without coronary artery disease (CAD) (n=80, 53 ± 6w, 53 ± 6wo). Participants arrived fasted for 
at least 12 hours and consume a randomized treatment consisting of caffeine 200 mg or placebo 
(Shechter et al., 2011). The FMD was measured in the brachial artery using a 15- to 6- MHz 
ultrasound system (HP SONOS 7500 cv System, Agilent Technologies, Inc., Andover, MA) one 
hour after ingestion. This measure used a pressure occlusion cuff to reduce blood flow prior to 
measures with ultrasound Doppler and blood vessel diameter after deflation (Shechter et al., 
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2011). The results revealed that caffeine significantly increased (p <0.001) FMD in the brachial 
artery in participants without CAD compared to placebo (Shechter et al., 2011). The results 
differ from exercise trials in that, exercise studies do not include participants with a chronic 
disease. Therefore comparisons and conclusions are difficult to compare. However the results of 
this study are important supporting the possible effect that caffeine may increase FMD in the 
brachial artery. Overall blood flow is not well researched in anaerobic research with the 
exception of heart rate, blood pressure, and ECG. 
Summary 
The effect of cocktail supplements or “pre-workout” supplements containing L-arginine 
nitrate and caffeine are not fully understood related to anaerobic performance. There is an 
apparent absence for multi-ingredient supplement regulation. Furthermore, there is a lack of 
comparative research comparing individual ingredients to multi-ingredients. There is no 
definitive dose for caffeine or nitric oxide to produce ergogenic effect. 
Research questions 
1. What are the short term effects of using pre-workout supplements within a healthy adult 
male population?  
  
2. Does a single dose of caffeine improve the anaerobic performance compared to a cocktail 
pre-workout supplement?  
 
3. Does a cocktail pre-workout supplement improve blood flow measures compared a single 
dose of caffeine? 
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CHAPTER 3. METHODS 
Experimental approach to the problem 
The purpose of the study was to examine the acute ergogenic effects of a single 
ingredient caffeine, compared to combined mixture: arginine nitrate, caffeine and other, and 
placebo. This study used a randomized, double-blind, placebo controlled, and crossover design.  
Participants and recruitment  
Fifteen recreationally active males (age 18-35 yrs) were recruited for this study. 
Recruitment flyers and North Dakota State University listservs were used to recruit participants 
(Appendix D, Appendix E). After preliminary email screening participants were scheduled for a 
familiarization trial.  After receiving study explanation and time to ask questions, participants 
were asked to sign written informed consent. The informed consent and protocol was approved 
by the North Dakota State University Internal Review Board (Appendix B, Appendix A). For the 
first visit the participants were screened using the PAR-Q risk stratification form (ACSM, 2000). 
The participants were required to be screened for excess or absent caffeine use to classify as 
habitual or nonhabitual users (Appendix C). In addition to the completion of the informed 
consent, PAR-Q, and caffeine food frequency questionnaire (CFFQ), participants were required 
to complete a Health History Questionnaire (HHQ). The inclusion criteria included: 1) caffeine 
consumption ≥100 mg or ≤ 500 mg of caffeine per day (Graham, 2001a), as estimated by a study 
team created CFFQ; 2) no current chronic use of another supplement within 30 days as described 
by Kedia et al. (2014); 3) any chronic disease including but not limited to: affecting 
cardiovascular, nervous system, and digestive system or other health problems identified by 
HHQ 4) non-smoking males including all nicotine products. Females were not recruited due to 
the menstrual cycles and oral contraceptives degradation effect on caffeine as described by 
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Timmins et al. (2014). All participants were required to be self-reported resistance trained with at 
least 6 months experience and maintain at least 3 hours of overall exercise per week.  
Supplements and placebo 
The pre-workout supplement (PRE) was commercially available Iron Pump™ (fruit punch 
flavored, MusclePharm, Denver, Colorado). The dose used for PRE was determined to be one 
scoop, i.e. 6 g, the amount recommend for pre-workout by the manufacturer.  The caffeine 
supplement (CAF) used for the study was a commercially available caffeine pill ground, using a 
mortar and pestle in 350 mg doses. (PROLAB Nutrition, Chatsworth, CA).  
Figure 2. Prolab caffeine pill ingredient list (Caffeine, PROLAB Nutrition, Chatsworth, CA). 
One individual pill contains 200 mg caffeine 
Pills were cut in half using a prescription tablet cutter (EZY Dose Safety Shield Tablet 
Cutter, Apothecary Products, Inc. ®, Burnsville, MN). Those doses were then mixed with fruit 
punch flavored, 5 calorie sweetened drink (Crystal Light, Northfield, IL). The dosage was 
determined after extracting the caffeine from 600 mg of PRE, in a pure chloroform solution for 
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24 hours. The assumption was that all the caffeine dissolved in the chloroform solution. Then 
through Nuclear Magnetic Resonance (NMR) spectroscopy, the chloroform solution extract 
showed that the 600 mg of powder contains 35 mg of pure caffeine. The serving size of PRE is 6 
g therefore the approximate dose of caffeine was 350 mg. The placebo dose used was a corn 
starch mix with a fruit punch flavored, 5 calorie sweetened drink (Crystal Light, Northfield, IL). 
Both PLA and CAF supplements were an iso-caloric match similar in taste, color and texture to 
the PRE supplement.  
All the supplements were placed into opaque vials which were independently double-
blinded into envelopes as described by Kalmar et al. (1999). During each trial the participants 
were randomly assigned one of the following: (PRE), (CAF), or (PLA). The subsequent trials 
(T2 and T3) maintained random assignment through double-blinding procedure discussed later. 
The blinder was otherwise not involved with the study and each subject had their own manila 
envelope, handled by a research assistant, containing the double-blind, coded vials. The research 
assistant on the day of each trial selected one envelope containing a vial for participant 
consumption. The vial was then mixed in 12 oz of cold bottled water in an opaque blender bottle 
and mixed utilizing a blender ball (Blender Bottle, Lehi, UT). One assistant was the primary 
observer in mixing and ensuring full consumption of each supplement and was excluded from 
subsequent data collection.  
Procedures 
A protocol-trained undergraduate/graduate student research team led participants through 
the procedure using a protocol spreadsheet and checklist (Appendix F, Appendix G). Participants 
were asked to attend four visits to the Muscle, Metabolism, and Ergogenics Lab (MME Lab) 
(NDSU, Fargo, ND). Participants were further instructed on a familiarization procedure with the 
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Biodex System 4 dynamometer (Biodex Medical Systems, Shirley, NY) as described by Astorino 
et al. (2010b). Furthermore the participants’ individualized Biodex seat measurements were 
recorded (Astorino et al., 2010b). The use of Biodex is both reliable and valid (Timmins et al., 
2014). Participants received a written instruction handout at the end of the FAM to prepare for 
study procedures (Appendix H). This handout included restrictions, times, and verbal instruction 
on appropriate actions and attire during trials. The three remaining visits were testing trials (T1, 
T2, and T3) conducted at the same time as schedules allowed at least 48 hours between trials for 
the duration of the study. Participants were provided a handout with instructions for T1, T2, and 
T3 (Appendix I).   
Table 4 
Completed measurements for each trial (T1, T2, T3) 
 Measurements Baseline 30-Post Supp Post-Ex 60-Post Supp 
T1 
 
 T2 
 
 T3 
M-Vel 
V- r2 
V-C 
√ 
√ 
√ 
√ 
√ 
√ 
√ 
√ 
√ 
√ 
√ 
√ 
BP-sys 
BP-dia 
√ 
√ 
√ 
√ 
√ 
√ 
√ 
√ 
LAC √ √ √ √ 
NO sal √   √ 
POMs √ √  √ 
Visit 1 was comprised of a familiarization trial (FAM) utilized to measure preliminary 
data as well as give participants the ability to experience the exercise protocol prior to testing. 
Upon arrival participants had weight measured using a digital scale to the nearest 0.1 kg (Denver 
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Instruments DA-150, Denver, CO) and height to the nearest 0.5 cm using a stadiometer (Seca 
703 scale, Chino, CA), with jackets and shoes removed. The Biodex was preformatted (protocol 
preset measures) prior to participant preference. These measures were recorded to set each 
subsequent trial. The participants were then tested with an exercise protocol for maximum 
strength peak torque at 0 and 60 degrees to calculate adjusted exercise concentric towards and 
concentric away loads. Eccentric mechanisms were not used with the Biodex due to irregular 
movement patterns caused by the equipment. During FAM the pre-trial load measurement was 
adjustment to 40 percent maximum strength both directions to prevent error during testing. The 
smallest measures of the four numbers (with respect to one away and one towards) was used for 
testing trials to ensure participants were able to complete the entire trial. Strength numbers were 
further rounded to the nearest coordinated number in the Biodex selection.  Participants were 
instructed to fast overnight, and instructed to arrive for testing in a euhydrated state at the 
scheduled time no more than 7 days from FAM. 
For Visit 2, first testing trial (T1) and all succeeding visits 3-4 (respectively T2 and T3) 
participants arrived at the MME Lab during their assigned time. Participants self-reported no 
deviations from instruction sheet. Upon arrival participants were prepped for a 12-lead 
electrocardiogram (EKG), electrodes (3M multipurpose) before positioning the Biodex for 
participant specification. The participants remained seated for the duration of the trial with the 
exception of transferring to and from the Biodex. Participants were asked to relax for a minimum 
of five minutes to prior to recording baseline measures. Each trial used repeated standardized 
measures at baseline, 30 minutes post supplementation (30-Post Supp), immediately (within <1 
minute) post-exercise (Post-Ex), and 60 minutes post supplementation (60-Post Supp). After 
baseline measures, participants consumed one dose of blinded supplement (PRE, CAF, or PLA) 
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and remained stationary for 30 minutes. During this time participants were allowed to work on 
homework, use cellular devices, laptops, or tablets as long as these tasks were not over 
stimulating. Immediate post-exercise was timed for all ultrasound measures using an 
ACCUSPILT stop watch (ACCUSPLIT, Pleasanton, California) and repeated in the same time 
frame of all subsequent trials. The measures for T1, T2, and T3 are depicted in Table 10.  
Heart rate 
 The EKG measured heart rate and heart rate variability assessed by a five minute 
protocol both pre-consumption and 60 minute-post consumption as well as both pre- and 
immediately post-exercise. Heart rate was collected during exercise for all sets (1-5) each trial 
and was recorded as minimum and maximum with focus on peak heart rate. Heart rate was 
further monitored for abnormalities via EKG connection. Abnormalities were defined as 85 
percent maximum heart rate calculate from Max HR = 220 – age during rest or exercise. In case 
of emergency the lab was equipped with a telephone, research assistants were familiar or trained 
in CPR, and all assistants were able to locate the AED. 
Ultrasound measures 
All ultrasound measures were collected from the right arm using a Pulsed Wave Doppler 
on a Phillips HD11XE ultrasound system (Phillips, Eindhoven, Netherlands). The ultrasound 
system was equipped with a Phillips L12-5 mm Broadband Linear Array probe from 12-5Mhz 
for the measures. To ensure accuracy in all trials the ultrasound probe was traced in permanent 
ink during T1 baseline and each participant received a permanent marker to darken marks 
between trials. The ultrasound measures included mean blood flow velocity m/s2 (M-Vel), cross-
sectional diameter of the right brachial artery cm2 (V- r2), and vessel circumference cm2 (V-C).  
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Blood pressure 
Resting blood pressure (BP) was recorded using an American Diagnostic Corporation 
sphygmometer and stethoscope (American Diagnostic Corp, Hauppauge, NY). The BP 
measurement obtained at baseline was tracked using EKG input. BP measures were recorded as 
systolic and diastolic in mmHg. 
Blood lactate 
Blood lactate (LAC) was measured with a Nova Biomedical portable analyzer (Nova 
Biomedical, Waltham, Massachusetts) pre- and post-exercise, with the left hand and finger stick 
of the participant utilizing a BD 30 gauge safety lancet (BD, Franklin Lakes, NJ) in mm/dL.  
Salivary nitric oxide 
Salivary NO concentration test was administered pre-ingestion (Table 10) measured by 
(N-O Indicator Strips, HumanN, Greensboro, GA). Saliva was collected using a 15 ml disposable 
cup. Utilizing a 5 ml pipet with disposable tip each strip was fully saturated with at least enough 
saliva to repeat measures once. Results were measured as depleted, low, and optimal according 
to information supplied by the manufacturer.  
Modified profile of mood states 
The participant then completed the Modified Profile of Mood States (POMs) (Appendix 
J) (Mackenzie, 2001). POMs analysis collects the following cumulative mood states: Anger (0-
48), Confusion (0-28), Depression (0-60), Fatigue (0-28), Tension (0-36), and Vigor (0-32). 
These moods states are totaled into an accumulative POMs score (-32 to 200). According to 
author Mackenzie (2001) vigor was associated with preparedness prior to competition among a 
sample of recreational athletes average (Vigor = 17.78). Behavioral analysis is a test designed to 
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measure potential vigor and the ability for athletes to perform at international, club, and 
recreational levels (Mackenzie, 2001).  
Exercise protocol 
Utilizing the Biodex System 4, participants were measured during visit 1 for maximal 
strength peak torque at 0 degrees and 60 degrees for both peak elbow flexion and extension. The 
work load was adjusted in accordance with 40 percent of max for concentric-concentric flexion-
extension. The adjusted work load was tested for 5 sets of 10 repetitions with a 60 second rest 
period between sets. The primary measure recorded was dynamic work. Dynamic work (Joules, 
J) is defined as the total work (J) for flexion and extension actions summed after each set. All 
participants received constructive coaching to encourage full effort throughout the exercise trials. 
Restraint straps were used to maintain physical force and limit body movements in determining 
muscle torque and total work of muscle contraction. Each subsequent trial consisted of the same 
exercise protocol listed, 5 sets by 10 repetitions for all treatments.    
Statistical analysis 
Frequencies and means were estimated for age, height, and weight. Repeated measures 
ANOVA was used to estimate time compared to supplement. This method was related to 
participants measured multiple times equating to possible correlation between measures. The 
variance/co-variance was accessed using compound symmetry. All statistics were performed 
using SAS Institute Inc. 9.3, 2011 (Cary, NC). 
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CHAPTER 4. ACUTE EXERCISE RESPONSE OF CAFFEINE AND NITRIC OXIDE 
STIMULATING PRE-WORKOUT SUPPLEMENT AMONG HEALTHY MALE 
RECREATIONAL ATHLETES 
 
Abstract 
The effect of cocktail supplements or “pre-workout” supplements containing L-arginine 
nitrate and caffeine are equivocal, especially with regard to anaerobic performance. This is 
related to poor regulation and the rarity of compared individual ingredients. The purpose of this 
study was to compare anaerobic performance and blood flow of a pre-workout supplement 
containing L-arginine nitrate and caffeine to caffeine and placebo. In a randomized, double-blind 
crossover design, 12 resistance-trained males (caffeine users) completed three trials. Biodex 
concentric-concentric elbow flexion and extension (5 sets of 10 repetitions each) measured 
dynamic work. Ultrasound measured brachial artery blood flow assessed M-Vel, V- r2 and V-C. 
Statistical analyses revealed a significant difference in total dynamic work PRE to PLA 
(P<0.0001) and CAF to PLA (P<0.0001) but not PRE to CAF (P=0.9581). Furthermore, a 
significant difference V- r2  PRE to CAF (P=0.0391) and PLA to CAF (P=0.0070) and M-Vel 
PRE to CAF (P=0.0281). In conclusion, the PRE did not differ CAF in strength measures other 
than a difference in M-Vel. PRE did not greatly improve blood flow as CAF suggests 
vasoconstriction. PRE compared to PLA were not statically different in blood flow. Therefore 
the use of a cocktail supplement illustrated no difference beyond individual ingredient. This 
research may be useful for future cocktail supplement and Nitric Oxide research. 
Keywords: Cocktail mixtures, L-arginine, NO, Anaerobic exercise, ergogenic-aid 
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Introduction 
Nutritional ergogenic aids, also referred to as performance enhancing substances, dietary 
substances or practices are not a new idea (Katch, McArdle, & Katch, 2011; Mahan, Escott-
Stump, & Raymond, 2012). Athletes, whether professional, collegiate, or recreational, 
commonly use dietary supplements, however, all supplements are not, and should be evaluated 
for efficacy and safety (Buell et al., 2013). In recent years, all types of ergogenic nutritional aids 
have increased in availability. Gaining in popularity, ergogenic nutritional mixtures, which are a 
combination of consumable dietary supplements, have been called cocktails (Spradley et al., 
2012). These cocktail mixtures combine separate ergogenic substances that may improve 
performance alone but are generally not tested together. To better understand how cocktail mixes 
effect ergogenic potential, research is needed comparing specific cocktail mixtures to individual 
ingredients to identify ergogenic potential and safety beyond individual ingredients alone. The 
purpose of this literature review is to examine the separate potential ergogenic effects, safety and 
efficacy of single ingredients caffeine, and L-arginine nitrate alone, to estimate effects of the 
combined mixture.  
Cocktail pre-workout supplement 
Cocktail mixtures marketed as pre- and post-workout supplements are often specific to 
anaerobic training or resistance training (Kedia et al., 2014). A specific research focus has been 
on pre-workout supplements and investigated by a number of teams (Kedia et al., 2014; Hoffman 
et al., 2008; Smith, Fukuda, Kendall, & Stout, 2010; Spradley et al., 2012; Outlaw et al., 2014). 
It is difficult to show interrelation among studies because none of the listed studies used the same 
mixture products in research design.  
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“Iron Pump™ utilizes “Super Nitric Oxide” ION-3 Nitrate Technology to open up blood 
pathways into the muscles, improving the effectiveness of the ordinary molecule. As the world’s 
first molecularly-modified arginine, L-Arginine Nitrate is a fusion of l-arginine and nitric acid 
that increases blood flow to enhance distribution of nutrients.”  
 
Figure 1. A schematic diagram of the physiologic disposition of nitrate, nitrite, and nitric oxide 
from exogenous (dietary) and endogenous sources (Ivy, 2015).   
Nitric oxide, nitrate, nitrite, and L-arginine   
Iron Pump™ is promoted as an L-arginine nitrate supplement (MusclePharm, 2013). L-
arginine is a precursor to nitric oxide synthases, whereas, nitrate or nitrite are more immediate 
precursors to nitric oxide (Hord, Tang, & Bryan, 2009). The nitric oxide released by cells after 
synthesis or absorption of nitrate or nitrite, has a vasodilating effect that is localized in blood 
vessels (Mahan et al., 2012). There are a number of exogenic and endogenic pathways for nitric 
oxide as illustrated in Figure 1. Search terms for citations found using supplements or exercise in 
association with L-arginine, nitric oxide, nitrate, nitrite, caffeine, and caffeinated.  
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Further, the USDA Nutrient Database, the Food and Agriculture Organization (FAO), 
and World Health Organization (WHO) do not report any nitric oxide, nitrite, or nitrate (USDA, 
2015; FAO, 2015; WHO, 2015). There is more information available, about caffeine as an 
individual ingredient than L-arginine in research (Bescós, Sureda, Tur, & Pons, 2012). This 
compares to database search results including PubMed, Google Scholar, and ProQuest, caffeine 
as an individual supplement (≈ 94,000 hits) than L-arginine alone (≈ 33,000 hits).  
L-arginine is an essential amino acid that works to synthesize nitric oxide in cells (Hord 
et al., 2009; Mahan et al., 2012). Good dietary sources of nitric oxide include beets, beet root 
juice, kale, arugula, spinach, and swiss chard. Therefore the supplement is intended to mimic this 
natural process illustrated in Figure 1. 
The supplementation of L-arginine, or nitric oxide stimulation, included in cocktail 
mixtures have the ergogenic potential to enhance endurance exercise through cardiorespiratory 
adaptation and increased tolerance to exercise (Bescós et al., 2012; Bailey et al., 2010; Camic et 
al., 2010a; Camic et al., 2010b). In a systematic review, Bescós et al. (2012) found the majority 
of research on L-arginine or nitric oxide to be based on endurance ergogenic potential (e.g. 
aerobic exercise to exhaustion) rather than resistance training (e.g. measured muscular strength, 
muscular endurance, and anaerobic capacity ~Wingate test). These results warrant further 
investigation of nitric oxide and L-arginine related to resistance training. Another problem with 
L-arginine nitrate is that the ergogenic potential of the individual substance has yet to be 
established and have primarily shown results in cocktail mixtures (Bescós et al., 2012; Bailey et 
al., 2010; Camic et al., 2010a; Camic et al., 2010b). The article by Bescós et al. (2012) identified 
the lack of research involving nitric oxide in isolation. Therefore, further research analyzing 
these compounds in a mixture and as individual ingredients is important to better understand the 
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effects of combining cocktail supplements. However a single “dose” of beet-root juice costs 
approximately ≈ $15.00 (USD) (Swanson Health Products, 2015). 
Statement of the problem 
This inability to test for safety, purity, and to test for efficacy of the ergogenic potential 
of individually combined ergogenic substances is under-researched and needed. The combined 
effects of such mixtures may result in unwanted side effects, injury, or death (Bunsawat et al., 
2014; Jacobs et al., 2003). 
Purpose of the study 
The purpose of this literature review is to identify the need to investigate both 
combination mixtures as well as individual mixtures.  Therefore investigation into the ergogenic 
potential of the combination L-arginine nitrate and caffeine in comparison to caffeine alone or 
placebo will be reinforced.  
Hypothesis of the study 
The hypothesis of this research is that a single dose of caffeine will not illustrate 
difference from a combined mixture including a similar dose of caffeine in compared short term 
effects, anaerobic (ergogenic) performance, or blood flow measures. 
Methods 
Experimental approach to the problem 
The purpose of the study was to examine the acute ergogenic effects of a single 
ingredient caffeine, compared to combined mixture: arginine nitrate, caffeine and other, and 
placebo. This study used a randomized, double-blind, placebo controlled, and crossover design.  
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Subjects  
Fifteen recreationally active males (age 18-35 yrs) were recruited for this study. 
Recruitment flyers and North Dakota State University listservs were used to recruit participants 
(Appendix F, Appendix G). After preliminary email screening participants were scheduled for a 
familiarization trial.  After receiving study explanation and time to ask questions, participants 
were asked to sign written informed consent. The informed consent and protocol was approved 
by the North Dakota State University Internal Review Board (Appendix B, Appendix A). For the 
first visit the participants were screened using the PAR-Q risk stratification form (Appendix C) 
(ACSM, 2000). The participants were required to be screened for excess or absent caffeine use to 
classify as habitual or nonhabitual users (Appendix D). In addition to the completion of the 
informed consent, PAR-Q, and caffeine food frequency questionnaire (CFFQ), participants were 
required to complete a Health History Questionnaire (HHQ) (Appendix E). The inclusion criteria 
included: 1) caffeine consumption ≥100 mg or ≤ 500 mg of caffeine per day (Graham, 2001a), as 
estimated by a study team created CFFQ; 2) no current chronic use of another supplement within 
30 days as described by Kedia et al. (2014) 3) any chronic disease including but not limited to; 
affecting cardiovascular, nervous system, and digestive system or other health problems 
identified by HHQ 4) non-smoking males including all nicotine products. Females were not 
recruited due to the menstrual cycles and oral contraceptives degradation effect on caffeine as 
described by Timmins et al. (2014). All participants were required to be self-reported resistance 
trained with at least 6 months experience and maintain at least 3 hours of overall exercise per 
week.  
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Procedures 
A protocol-trained undergraduate/graduate student research team led participants through 
the procedure using a protocol spreadsheet and checklist (Appendix H, Appendix I). Participants 
were asked to attend four visits to the Muscle, Metabolism, and Ergogenics Lab (MME Lab) 
(NDSU, Fargo, ND). Participants were further instructed on a familiarization procedure with the 
Biodex System 4 dynamometer (Biodex Medical Systems, Shirley, NY) as described by Astorino 
et al. (2010b). Furthermore the participants’ individualized Biodex seat measurements were 
recorded (Astorino et al., 2010b). The use of Biodex is both reliable and valid (Timmins et al., 
2014). Participants received a written instruction handout at the end of the FAM to prepare for 
study procedures (Appendix J). This handout included restrictions, times, and verbal instruction 
on appropriate actions and attire during trials. The three remaining visits were testing trials (T1, 
T2, and T3) conducted at the same time as schedules allowed at least 48 hours between trials for 
the duration of the study. Participants were provided a handout with instructions for T1, T2, and 
T3 (Appendix J).   
 
 
58 
 
Table 4 
Completed measurements for each trial (T1, T2, T3) 
 Measurements Baseline 30-Post Supp Post-Ex 60-Post Supp 
T1 
 
 T2 
 
 T3 
M-Vel 
V- r2 
V-C 
√ 
√ 
√ 
√ 
√ 
√ 
√ 
√ 
√ 
√ 
√ 
√ 
BP-sys 
BP-dia 
√ 
√ 
√ 
√ 
√ 
√ 
√ 
√ 
LAC √ √ √ √ 
NO sal √   √ 
POMs √ √  √ 
Visit 1 was comprised of a familiarization trial (FAM) utilized to measure preliminary 
data as well as give participants the ability to experience the exercise protocol prior to testing. 
Upon arrival participants had weight measured using a digital scale to the nearest 0.1 kg (Denver 
Instruments DA-150, Denver, CO) and height to the nearest 0.5 cm using a stadiometer (Seca 
703 scale, Chino, CA), with jackets and shoes removed. The Biodex was preformatted (protocol 
preset measures) prior to participant preference. These measures were recorded to set each 
subsequent trial. The participants were then tested with an exercise protocol for maximum 
strength peak torque at 0 and 60 degrees to calculate adjusted exercise concentric towards and 
concentric away loads. Eccentric mechanisms were not used with the Biodex due to irregular 
movement patterns caused by the equipment. During FAM the pre-trial load measurement was 
adjustment to 40 percent maximum strength both directions to prevent error during testing. The 
smallest measures of the four numbers (with respect to one away and one towards) was used for 
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testing trials to ensure participants were able to complete the entire trial. Strength numbers were 
further rounded to the nearest coordinated number in the Biodex selection.  Participants were 
instructed to fast overnight, and instructed to arrive for testing in a euhydrated state at the 
scheduled time no more than 7 days from FAM. 
For Visit 2, first testing trial (T1) and all succeeding visits 3-4 (respectively T2 and T3) 
participants arrived at the MME Lab during their assigned time. Participants self-reported no 
deviations from instruction sheet. Upon arrival participants were prepped for a 12-lead 
electrocardiogram (EKG), electrodes (3M multipurpose) before positioning the Biodex for 
participant specification. The participants remained seated for the duration of the trial with the 
exception of transferring to and from the Biodex. Participants were asked to relax for a minimum 
of five minutes to prior to recording baseline measures. Each trial used repeated standardized 
measures at baseline, 30 minutes post supplementation (30-Post Supp), immediately (within <1 
minute) post-exercise (Post-Ex), and 60 minutes post supplementation (60-Post Supp). After 
baseline measures, participants consumed one dose of blinded supplement (PRE, CAF, or PLA) 
and remained stationary for 30 minutes. During this time participants were allowed to work on 
homework, use cellular devices, laptops, or tablets as long as these tasks were not over 
stimulating. Immediate post-exercise was timed for all ultrasound measures using an 
ACCUSPILT stop watch (ACCUSPLIT, Pleasanton, California) and repeated in the same time 
frame of all subsequent trials. The measures for T1, T2, and T3 are depicted in Table 10.  
Heart rate 
 The EKG measured heart rate and heart rate variability assessed by a five minute 
protocol both pre-consumption and 60 minute-post consumption as well as both pre- and 
immediately post-exercise. Heart rate was collected during exercise for all sets (1-5) each trial 
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and was recorded as minimum and maximum with focus on peak heart rate. Heart rate was 
further monitored for abnormalities via EKG connection. Abnormalities were defined as 85 
percent maximum heart rate calculate from Max HR = 220 – age during rest or exercise. In case 
of emergency the lab was equipped with a telephone, research assistants were familiar or trained 
in CPR, and all assistants were able to locate the AED. 
Ultrasound measures 
All ultrasound measures were collected from the right arm using a Pulsed Wave Doppler 
on a Phillips HD11XE ultrasound system (Phillips, Eindhoven, Netherlands). The ultrasound 
system was equipped with a Phillips L12-5 mm Broadband Linear Array probe from 12-5Mhz 
for the measures. To ensure accuracy in all trials the ultrasound probe was traced in permanent 
ink during T1 baseline and each participant received a permanent marker to darken marks 
between trials. The ultrasound measures included mean blood flow velocity m/s2 (M-Vel), cross-
sectional diameter of the right brachial artery cm2 (V- r2), and vessel circumference cm2 (V-C).  
Blood pressure 
Resting blood pressure (BP) was recorded using an American Diagnostic Corporation 
sphygmometer and stethoscope (American Diagnostic Corp, Hauppauge, NY). The BP 
measurement obtained at baseline was tracked using EKG input. BP measures were recorded as 
systolic and diastolic in mmHg. 
Blood lactate 
Blood lactate (LAC) was measured with a Nova Biomedical portable analyzer (Nova 
Biomedical, Waltham, Massachusetts) pre- and post-exercise, with the left hand and finger stick 
of the participant utilizing a BD 30 gauge safety lancet (BD, Franklin Lakes, NJ) in mm/dL.  
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Salivary nitric oxide 
Salivary NO concentration test was administered pre-ingestion (Table 10) measured by 
(N-O Indicator Strips, HumanN, Greensboro, GA). Saliva was collected using a 15 ml disposable 
cup. Utilizing a 5 ml pipet with disposable tip each strip was fully saturated with at least enough 
saliva to repeat measures once. Results were measured as depleted, low, and optimal according 
to information supplied by the manufacturer.  
Modified profile of mood states 
The participant then completed the Modified Profile of Mood States (POMs) (Appendix 
K) (Mackenzie, 2001). POMs analysis collects the following cumulative mood states: Anger (0-
48), Confusion (0-28), Depression (0-60), Fatigue (0-28), Tension (0-36), and Vigor (0-32). 
These moods states are totaled into an accumulative POMs score (-32 to 200). According to 
author Mackenzie (2001) vigor was associated with preparedness prior to competition among a 
sample of recreational athletes average (Vigor = 17.78). Behavioral analysis is a test designed to 
measure potential vigor and the ability for athletes to perform at international, club, and 
recreational levels (Mackenzie, 2001).  
Exercise protocol 
Utilizing the Biodex System 4, participants were measured during visit 1 for maximal 
strength peak torque at 0 degrees and 60 degrees for both peak elbow flexion and extension. The 
work load was adjusted in accordance with 40 percent of max for concentric-concentric flexion-
extension. The adjusted work load was tested for 5 sets of 10 repetitions with a 60 second rest 
period between sets. The primary measure recorded was dynamic work. Dynamic work (Joules, 
J) is defined as the total work (J) for flexion and extension actions summed after each set. All 
participants received constructive coaching to encourage full effort throughout the exercise trials. 
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Restraint straps were used to maintain physical force and limit body movements in determining 
muscle torque and total work of muscle contraction. Each subsequent trial consisted of the same 
exercise protocol listed, 5 sets by 10 repetitions for all treatments.    
Supplements and placebo 
The pre-workout supplement (PRE) was commercially available Iron Pump™ (fruit punch 
flavored, MusclePharm, Denver, Colorado). The dose used for PRE was determined to be one 
scoop, i.e. 6 g, the amount recommend for pre-workout by the manufacturer.  The caffeine 
supplement (CAF) used for the study was a commercially available caffeine pill ground, using a 
mortar and pestle in 350 mg doses. (PROLAB Nutrition, Chatsworth, CA).  
Pills were cut in half using a prescription tablet cutter (EZY Dose Safety Shield Tablet 
Cutter, Apothecary Products, Inc. ®, Burnsville, MN). Those doses were then mixed with fruit 
punch flavored, 5 calorie sweetened drink (Crystal Light, Northfield, IL). The dosage was 
determined after extracting the caffeine from 600 mg of PRE, in a pure chloroform solution for 
24 hours. The assumption was that all the caffeine dissolved in the chloroform solution. Then 
through Nuclear Magnetic Resonance (NMR) spectroscopy, the chloroform solution extract 
showed that the 600 mg of powder contains 35 mg of pure caffeine. The serving size of PRE is 6 
g therefore the approximate dose of caffeine was 350 mg. The placebo dose used was a corn 
starch mix with a fruit punch flavored, 5 calorie sweetened drink (Crystal Light, Northfield, IL). 
Both PLA and CAF supplements were an iso-caloric match similar in taste, color and texture to 
the PRE supplement.  
All the supplements were placed into opaque vials which were independently double-
blinded into envelopes as described by Kalmar et al. (1999). During each trial the participants 
were randomly assigned one of the following: (PRE), (CAF), or (PLA). The subsequent trials 
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(T2 and T3) maintained random assignment through double-blinding procedure discussed later. 
The blinder was otherwise not involved with the study and each subject had their own manila 
envelope, handled by a research assistant, containing the double-blind, coded vials. The research 
assistant on the day of each trial selected one envelope containing a vial for participant 
consumption. The vial was then mixed in 12 oz of cold bottled water in an opaque blender bottle 
and mixed utilizing a blender ball (Blender Bottle, Lehi, UT). One assistant was the primary 
observer in mixing and ensuring full consumption of each supplement and was excluded from 
subsequent data collection.  
Statistical analysis 
Frequencies and means were estimated for age, height, and weight. Repeated measures 
ANOVA was used to estimate time compared to supplement. This method was related to 
participants measured multiple times equating to possible correlation between measures. The 
variance/co-variance was accessed using compound symmetry. All statistics were performed 
using SAS Institute Inc. 9.3, 2011 (Cary, NC). 
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Results 
During the months in which active recruitment for the study occurred (October 2015 until 
March 2016), fifteen subjects were initially recruited. After completing the informed consent, 
HHQ, PAR-Q, and CFFQ participants with identified health problems were removed from the 
study. One participant was dropped due to an uncommon adverse event during exercise testing 
and two participants were removed due to failure to report for testing. The participant removal 
was related to a failure to follow fasting protocol resulting in greater than a 12 hour fast.  The 12 
remaining participants completed the three trials (PRE, CAF, and PLA) in random order. 
Participant demographics are displayed in Table 1. Two participants did not consume caffeine 
for the duration of the study to washout prior consumed pre-workout supplements. Participants 
that used supplements prior to the study met required daily habitual caffeine intake during 
recruitment. All subjects followed study requirements according to self-reports, no deviations 
reported. Trials ended when data began to illustrate comparable results suggesting that the data 
collected would be testable to answer research questions.  
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Table 5 
 Sex, age, caffeine use, height, and weight and 12 subjects completing pre-workout 
crossover study 
  % n 
Sex (n= 12) 
Male 
 
 
100 
 
 
12 
 Age (n=12) 22.75 ± 4.51 
      Under 18 
18 – 24 
25 – 35 
 
0 
75 
25 
 
 
 
0 
9 
3 
 
 Habitual caffeine use mg/day (n= 12) 
  0 – 99  
100 – 199 
200 – 299 
300 – 399 
400 – 499 
>500 
 
0 
16.6 
50 
16.6 
16.6 
0 
 
0 
2 
6 
2 
2 
0 
Height (n=12) 
 
 
183.4 ± 7.37 
 (166.05 to 193.99 cm) 
 
 Weight (n= 12) 
 
 
91.05 ± 17.77 
(57.85 to 133.77 kg) 
 
 
The following sections detail the results of individual tests used for the study. 
Heart rate 
 There were no correlations run on the EKG heart rate data. The situational heart rate data 
collected during exercise reached significance related to time but did not reach significance with 
respect to supplement. The individual data was measured as time 1, 2, 3, 4, or 5 with respect to 
the correlating set of exercise. Time measures for heart rate were significantly different for all 
treatments are as follows: time 1 to 4 (P=0.0282), time 1 to 5 (P=0.0003), time 2 to 4 
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(P=0.0412), time 2 to 5 (P=0.0005), and time 3 to 5 (P=0.0387) individual means are described 
in Figure 3. Heart rate was not recorded prior to exercise trial nor was it recorded after Post-
Exercise measures were collected.  
Figure 3. Max Heart Rate distribution of CAF, PLA, and PRE throughout all trials. 
Ultrasound data 
 Vessel diameter (V-r2) and circumference (V-C) and mean blood flow velocity (M-Vel) 
were all measured to test for effects of the various trials on the relationships among V-r2, V-C 
and M-Vel. The measurements for each subject’s V-r2 and V-C, the means were 0.46766 ± 
0.06826 cm (0.3260 to 0.6670) and 1.45168 ± 0.21802 cm2 (1.010 to 2.100) with respect.  M-Vel 
at baseline was 18.437 ± 8.786 m/s2; 30-Post Supp 14.422 ± 5.812 m/s2; Post-Ex 63.578 ± 
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15.683 m/s2; 60-Post Supp 20.789 ±9.582 m/s2. One measure was not recorded 60-Post Supp 
because the Post-Ex was performed at the same time point 60 minutes from supplementation. 
Table 6  
Mean velocity variable analyses among recreational active males (n=12) 
Time Supplement 
N 
Obs N Mean 
Std 
Dev Minimum Maximum 
Baseline CAF 12 12 22.384 11.474 9.710 50.100 
PLA 12 12 17.032 5.484 7.980 25.900 
PRE 12 12 15.896 7.598 8.100 35.700 
30 Post Supp CAF 12 12 18.036 6.181 7.630 30.100 
PLA 12 12 13.448 5.201 6.310 23.900 
PRE 12 12 11.782 4.396 5.690 20.800 
Post Ex CAF 12 12 65.917 18.334 26.500 93.300 
PLA 12 12 61.558 18.302 37.500 103.000 
PRE 12 12 63.258 10.047 47.600 80.400 
60 Post Supp CAF 12 11 24.600 12.067 11.400 56.800 
PLA 12 12 19.864 8.302 9.870 38.800 
PRE 12 12 18.220 7.737 1.440 33.500 
The ultrasound data did not identify a correlation between M-Vel and V-r2 or M-Vel and 
V-C. However, vessel V-r2 and V-C were perfectly correlated (R=0.96944) excluding only one 
outlying point (Figure 4). Mean difference in velocity reached statistical significance in relation 
to time baseline to Post-Ex (P<0.0001), 30-Post Supp to Post-Ex (P<0.0001), and Post-Ex to 60-
Post Supp (P<0.0001).  The repeated supplement measures PRE to CAF were statistically 
different (P=0.0281).  
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Table 7  
Vessel diameter variable analyses among recreational active males (n=12) 
Time Supplement 
N 
Obs N Mean 
Std 
Dev Minimum Maximum 
Baseline CAF 12 12 0.436 0.058 0.352 0.526 
 PLA 12 12 0.442 0.065 0.351 0.522 
 PRE 12 12 0.445 0.054 0.360 0.527 
30 Post Supp CAF 12 12 0.437 0.055 0.349 0.518 
 PLA 12 12 0.448 0.065 0.355 0.524 
 PRE 12 12 0.446 0.081 0.326 0.624 
Post Ex CAF 12 12 0.499 0.056 0.387 0.598 
 PLA 12 12 0.531 0.069 0.407 0.655 
 PRE 12 12 0.519 0.064 0.431 0.667 
60 Post Supp CAF 12 11 0.457 0.051 0.381 0.538 
 PLA 12 12 0.476 0.067 0.390 0.593 
 PRE 12 12 0.474 0.065 0.386 0.618 
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Figure 4. Blood Flow Data Correlation –Vessel and Velocity Variables Group by Supplement 
The V-r2 furthermore attained significant difference in relation to time; baseline to 
Post-Ex (P<0.0001), baseline to 60-Post Supp (P<0.0001), 30-Post Supp to Post-Ex 
(P<0.0001), 30-Post Supp to 60-Post Supp (P=0.0001), and Post-Ex to 60-Post Supp 
(P<0.0001). The V-r2 did reach a significantly greater affect in relation to supplement PRE 
than CAF (P=0.0391) and PLA than CAF (P=0.0070). 
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Blood pressure data 
 All BP recorded were within normal range for each participant. The study did not include 
participants with hypertension; therefore all resting measures were required to be less than 
120/80 mmHg. Both BP-sys and BP-dia illustrated a non-linear positive relationship. There were 
no further correlation or comparison to the previous ultrasound measures. The repeated measure 
mixed procedure found significance related to time but not supplement for both systolic BP and 
diastolic BP. Systolic BP met significant difference baseline to Post-Ex (P<0.0001), 30-Post 
Supp to Post-Ex (P<0.0001), and Post-Ex to 60-Post Supp (P<0.0001). Diastolic BP reached 
significance baseline to Post-Ex (P=0.0011) and baseline to 60-Post Supp (P=0.0021). The 
results weigh in negative effect with the exception of Post-Ex to 60-Post Supp which was 
positive. 
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Table 8 
 Blood Pressure-systolic variable analyses among recreational active males (n=12) 
Time Supplement 
N 
Obs N Mean Std Dev Minimum Maximum 
Baseline CAF 12 12 121.000 7.508 108.000 132.000 
PLA 12 12 121.500 11.446 108.000 150.000 
PRE 12 12 121.833 8.922 110.000 136.000 
30 Post 
Supp 
CAF 12 12 123.833 8.462 112.000 138.000 
PLA 12 12 121.833 10.735 112.000 140.000 
PRE 12 12 123.833 9.044 112.000 140.000 
Post Ex CAF 12 12 136.167 15.828 118.000 172.000 
PLA 12 12 134.500 14.848 114.000 160.000 
PRE 12 12 133.333 18.297 118.000 180.000 
60 Post 
Supp 
CAF 12 12 126.167 10.426 108.000 144.000 
PLA 12 12 124.667 9.847 116.000 142.000 
PRE 12 12 124.000 8.356 112.000 136.000 
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Table 9  
Blood Pressure-diastolic variable analyses among recreational active males 
(n=12) 
Time Supplement 
N 
Obs N Mean Std Dev Minimum Maximum 
Baseline CAF 12 12 79.000 6.467 70.000 90.000 
PLA 12 12 78.833 5.357 72.000 92.000 
PRE 12 12 79.667 8.773 58.000 90.000 
30 Post 
Supp 
CAF 12 12 81.500 4.275 76.000 90.000 
PLA 12 12 80.167 6.177 72.000 92.000 
PRE 12 12 81.000 8.634 62.000 92.000 
Post Ex CAF 12 12 83.833 4.303 76.000 90.000 
PLA 12 12 81.667 5.314 72.000 90.000 
PRE 12 12 82.000 6.030 72.000 90.000 
60 Post 
Supp 
CAF 12 12 83.500 4.523 78.000 90.000 
PLA 12 12 80.333 4.579 72.000 90.000 
PRE 12 12 83.167 5.219 76.000 92.000 
Blood lactate 
 Blood lactate (LAC) data showed no correlation to BP-sys, BP-dia, or POMs score. The 
mixed model of repeated measures found significance related to time but not supplement. The 
significant data related to time is as follows:  baseline to Post-Ex (P<0.0001), baseline to 60-Post 
Supp (P<0.0001), 30-Post Supp to Post-Ex (P<0.0001), 30-Post Supp to 60-Post Supp 
(P<0.0001), and Post-Ex to 60-Post Supp (P<0.0001). 
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Table 10 
 Blood Lactate variable analyses among recreational active males (n=12) 
Time Supplement 
N 
Obs N Mean Std Dev Minimum Maximum 
Baseline CAF 12 12 0.775 0.176 0.500 1.000 
PLA 12 12 1.000 0.386 0.400 1.600 
PRE 12 12 0.858 0.268 0.400 1.300 
30 Post 
Supp 
CAF 12 12 0.967 0.427 0.400 1.800 
PLA 12 12 1.042 0.570 0.300 2.500 
PRE 12 12 0.950 0.430 0.300 1.700 
Post Ex CAF 12 12 3.125 1.223 1.700 5.200 
PLA 12 12 2.692 0.834 1.400 3.700 
PRE 12 12 3.183 1.084 1.200 5.200 
60 Post 
Supp 
CAF 12 12 2.042 0.854 0.900 4.000 
PLA 12 12 1.858 0.817 0.700 3.000 
PRE 12 11 1.809 0.793 1.000 3.000 
  
Salivary nitric oxide 
 Salivary NO (NO sal) data was not run as a statistical model due to question of validity 
and reliability in relation to high qualitative unspecific measure. There were no correlations 
related to other data collected. The frequencies of the various NO strip results are shown below 
in Figure 5.  
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 Figure 5. Salivary Nitric Oxide strips measured at 60 minutes post supplement consumption. 
POMs data 
 Modified Profile of Mood States data did not show correlation to individual mood 
attributes. Measures of individual mood attributes were not statistically analyzed for the current 
paper. The POMs Vigor attribute means and standard deviations were: PRE 13.08 ± 6.21 and 
13.67 ± 6.07; CAF 12.50 ± 7.83 and 11.58 ± 7.04; PLA 13.5 ±6.37 and 14.42 ± 5.54 with respect 
to 30-Post Supp and 60-Post Supp. Furthermore, there was no correlation of the totaled POMs 
score to blood lactate, systolic BP or diastolic BP. Modified Profile of Mood States score 
however reached significance with respect to both time and supplement. In relation to time 
baseline to 60-Post Supp was significantly different (P=0.0005). The repeated measures of 
supplement met significance where the PLA score was statistically greater than PRE (P=0.0358) 
and CAF (P=0.0426).    
0
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Table 11 
 POMS_Score variable analyses among recreational active males 
(n=12) 
Time 
Supplemen
t 
N 
Obs N Mean 
Std 
Dev Minimum Maximum 
Baseline CAF 12 12 4.167 11.175 -16.000 27.000 
PLA 12 12 8.417 12.894 -9.000 32.000 
PRE 12 12 2.833 10.590 -15.000 18.000 
30 Post 
Supp 
CAF 12 12 -3.167 10.035 -21.000 11.000 
PLA 12 12 1.750 12.793 -18.000 22.000 
PRE 12 12 -0.583 10.958 -21.000 20.000 
60 Post 
Supp 
CAF 12 12 -1.500 11.751 -11.000 32.000 
PLA 12 12 1.083 11.966 -15.000 22.000 
PRE 12 12 -3.083 10.202 -21.000 20.000 
Biodex data 
 Biodex dynamic work was not assessed for correlation with other variables. The dynamic 
work data reached significance for repeated measures comparison to supplement. The dynamic 
work J reached significant difference for PRE to PLA (P<0.0001) and PLA to CAF (P<0.0001). 
However the data did not present significance PRE to CAF (P=0.9581) nor regarding the 
repeated measure of time (P=0.3933).     
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Figure 6. Dynamic Work variable analyses among recreational active males (n=12). 
1 2 3 4 5
CAF 1119.200 1150.383 1140.583 1119.350 1087.658
PLA 1020.725 1058.733 1052.700 1040.442 1018.467
PRE 1102.758 1129.442 1129.275 1114.258 1116.417
Max_CAF 1416.4 1423.7 1424.8 1423.2 1404.7
Max_PRE 1524.7 1470.3 1463.2 1429.9 1434.9
Min_CAF 778.7 846.1 820.3 845.1 696.5
Min_PRE 632.9 727.0 746.7 769.9 783.5
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Table 12  
Dynamic Work variable analyses among recreational active males (n=12) 
Time Supplement N Obs N Mean Std Dev Minimum Maximum 
1 CAF 12 12 1119.200 194.203 778.700 1416.400 
PLA 12 12 1020.725 148.622 784.400 1252.600 
PRE 12 12 1102.758 233.325 632.900 1524.700 
2 CAF 12 12 1150.383 183.166 846.100 1423.700 
PLA 12 12 1058.733 140.240 861.200 1358.000 
PRE 12 12 1129.442 202.781 727.000 1470.300 
3 CAF 12 12 1140.583 181.748 820.300 1424.800 
PLA 12 12 1052.700 142.298 836.000 1361.200 
PRE 12 12 1129.275 192.189 746.700 1463.200 
4 CAF 12 12 1119.350 198.929 845.100 1423.300 
PLA 12 12 1040.442 130.969 825.500 1336.500 
PRE 12 12 1114.258 177.824 769.900 1429.900 
5 CAF 12 12 1087.658 217.386 696.500 1404.700 
PLA 12 12 1018.467 119.725 861.100 1319.800 
PRE 12 12 1116.417 176.001 783.500 1434.900 
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Discussion 
 The primary focus of this study was to compare a 350 mg dose of caffeine to a cocktail 
supplement containing caffeine and NO, and placebo in short term effects, anaerobic 
performance, and blood flow effect. Specifically, the study was designed to test differences 
among a single dose of caffeine, a combined cocktail supplement, and placebo for short term 
effects, anaerobic (ergogenic) performance, and blood flow measures.  
The findings from this study suggest that recreational male athletes improve performance 
with the acute consumption of both PRE and CAF supplements. There was no significant 
evidence to statistically illustrate a difference between both supplements. Nonetheless, there 
were pronounced trends related to supplement versus placebo groups. The following sections 
detailed individual measurement results.   
Heart rate 
 There were no significant changes in HR other than those found at time measures 1-5. 
The HR was expected to increase as exercise increased in duration due to increased intensity of 
work performed from set 1 to the final set 5. Spradley et al. (2012) found similar results that 
supplement groups had higher HR compared to placebo. Bunswat et al. (2014) found CAF 
significantly increased Max HR compared to PLA. Although these researchers found 
significance this study did not. The results represent a noteworthy outcome that both 
supplements (PRE and CAF) had greater Max HR and mean HR than placebo. These results 
further concur with Hudson et al. (2008) that CAF increased HR compared to aspirin and PLA. 
The distribution of maximum heart rate can be seen in Figure 3. Maximum HR also appeared 
less controlled in the CAF group than PLA and PRE.  
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Ultrasound data  
Vessel diameter and V-C measures were difficult points to obtain as all data points had to 
be collected directly from the ultrasound machine. The method of collection also demonstrated a 
high probability for error. The V-r2 measures were analyzed using a point trace method 
preprogrammed on the ultrasound machine. This method required the vessel to be marked at the 
two points on the lumen (widest part of the lumen) in the cross-sectional image. This generated 
the diameter and each image had to be analyzed for all collected data points. Inversely V-C 
measures were recorded utilizing a preset point and circle method. This method required the 
lumen to be marked and expanded using a circle that encompasses the vessel. Both measures had 
high probability for error but values still correlated (R=0.96944, Figure 4).  
Finally, ultrasound data reached significance in M-Vel, V-r2 and, V-C. However, these 
increases in vessel velocity and size are expected with increased blood flow. The measures 
recorded illustrate a primary a correlation between pre- and post-exercise blood flow. In relation 
V-r2 and V-C demonstrated increased blood flow from baseline to 60-Post Supp. The V-r2 
significance between baseline to 60-Post Supp (P<0.0001) suggests a possible trend before and 
after supplementation. Furthermore 30-Post Supp to 60-Post Supp (P=0.0001) suggests a 
possible lasting effect pre and post-exercise. The V-r2 statistical significance between PRE to 
CAF (P=0.0391) and PLA to CAF (P=0.0070) may suggest increased vasodilation of both PRE 
and PLA but not CAF. This result could be related to the vasoconstriction properties of caffeine 
during exercise (Rosenbloom & Coleman, 2012). Similar difference was found with M-Vel 
comparing PRE to CAF (P=0.0281). As identified previously this could indicate improved blood 
flow in PRE versus CAF.   
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Blood pressure data 
 The systolic BP and diastolic BP measures met significance with respect to time however 
this was an expected outcome. Further the BP measures were not measured within one minute 
immediate post-exercise to prevent interference with the ultrasound measures collected.  
Blood lactate 
 Blood lactate (LAC) showed significance with respect to time. These measures increased 
in relation to exercise when compared to pre- or post-exercise measures. The exception to this 
was the significant difference 30-Post Supp to 60-Post Supp (P<0.0001) in which the measures 
of LAC may have maintained higher levels due to energy system recovery post-exercise (Katch 
et. al., 2011). Furthermore the Post Ex and 60-Post Supp measures were collected in close 
proximity related to time.  
Salivary nitric oxide 
 Salivary NO (NO sal) was not a scientifically validated test and was used merely for 
comparison to groups. The notable outcome was that PRE measures had an almost 82% accuracy 
in depicting optimal NO levels. Participants that consumed CAF had no optimal measures 
conversely PLA had one optimal measure. Dietary factors can further affect the data outcome. 
Although this data set does not validate this measure, results illustrate promise for future studies.  
POMs data 
 POMs is a validated test used to predict the outcome performance or ready to perform in 
all types of athletes (Mackenzie, 2001). The POMs Vigor attribute means did not reflect those 
found within the larger data set (Mackenzie, 2001). However the significance difference PLA to 
PRE (P=0.0358) and PLA to CAF (P=0.0426) in overall score reflects a possible relationship to 
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altered mood states and perceived supplement use. The POMs test reflects individual motivation 
to complete the measure. Individuals trained on POMs perform as expected whereas untrained 
individuals may not test effectively. This was apparent in the variation of baseline POMs scores. 
The current study used an early morning protocol, which may lower subject motivation. In 
addition, the statistical results should include individual attributes such as Vigor for future 
studies. Finally two subjects reported self-identified reactions correctly identifying blinded 
supplements. The supplement reactions as self-reported could add impact to results and 
motivation. 
Biodex data 
 Biodex dynamic work measure met significance for PRE to PLA (P<0.0001) and CAF to 
PLA (P<0.0001) but not PRE to CAF (P=0.9581). This illustrates that although muscular 
performance was improved compared to PLA, performance was not altered beyond the use of 
PRE or CAF. These data results show that caffeine may have had a primary effect of muscular 
performance as both supplements were presumed to contain a similar dose of caffeine. The other 
ingredients or possible ergogenic ingredients require further and individual testing to better 
understand this outcome.  
The findings from this study suggest that recreational male athletes improve performance 
with the acute consumption of both PRE and CAF supplements. There was no significant 
evidence to statistically illustrate a difference between both supplements. However the dynamic 
work more consistent with PRE than CAF during exercise illustrating a nonsignificant trend 
(Figure 5). Nonetheless, there were pronounced trends related to supplement versus placebo 
groups.     
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 Limitations 
There were some limitations to this research study. First, a small group of participants 
were tested in this protocol. An increased number of participants could have revealed different 
findings. Participants were increasingly difficult to find for this study as individuals did not want 
to give up the use of other supplements for washout periods. Others did not consume enough 
caffeine to be considered for the study. In addition this study used only male participants and 
should be further investigated using female participants. Second the early time of day (0600 – 
1000) was difficult for both caffeine restrictions and fasting requirements. Participants regularly 
consumed caffeine daily and were not able to consume breakfast prior to each trial. Third 
ultrasound measures collected required diverse practice with differences among participants 
(anatomical differences). The measures required multiple images to collect all desired data 
points. However, the technique was optimized by careful methods such as recording time and 
using a stop watch.  Fourth the lumen identification, V-r2 required two whereas V-C required 
one marker point to be manipulated to fit vessel. Both measures can only be analyzed on the 
ultrasound machine. Finally, the rest period could have been longer to better accommodate 
resting heart rate, resting blood pressure, and other baseline measures. Future studies should use 
30 to 60 instead of 15 minutes rest prior to baseline measures. 
Practical applications 
Implications for research and practice are that there were no significant changes when 
using a combined cocktail supplement to a single ingredient supplement. This presents a 
hypothetical outcome that there may not be a benefit to beyond a single known ingredient. The 
supplement regulations and measured ingredients are important to investigate for purity and 
efficacy of use. Strength and conditioning research can benefit from knowing the effectiveness of 
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individual ingredient compared to multiple ingredient research. Further research is needed to 
comparing individual ingredients to like cocktail supplements. In addition future investigations 
should include male and female participants. Future research related to NO and anaerobic 
exercise is needed. 
The results of this research do not fully articulate the total performance effects associated 
with these supplements in comparison to exercise and blood flow measures. Although both PRE 
and CAF did not greatly differ the investigation is not exclusive from further future 
investigations. As well the research warrants that supplement regulation by the FDA may 
positively impact future effects of cocktail supplements and those containing NO. 
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CHAPTER 5. CONCLUSION 
This study was designed to examine the short term performance enhancing effects of 
caffeine, compared to both a cocktail mixture including caffeine and placebo. Cocktail mixtures 
containing separate ergogenic substances may improve performance alone are not generally 
tested together. Examining the effects of individual as well as combined ingredient supplements 
may further the understanding of how ergogenic ingredients work together. Currently, there are 
no strict guidelines governing the distribution of most nutritional supplements. Along with 
increasing popularity, supplementing during exercise could increase risk for both safety and lack 
of efficacy. This apparent deficiency in guidance could ultimately result in over supplementation.  
The hypothesis of this research was that a single dose of caffeine will not illustrate 
difference from a combined mixture including a similar dose of caffeine compared to short term 
effects of anaerobic (ergogenic) performance and blood flow. 
The results of this research study revealed that acute effects of supplementation were 
similar across all three treatment groups. In addition, both PRE and CAF illustrated improved 
dynamic work beyond PLA with no difference between the two. Finally the blood flow measures 
weighed favorably to both PRE and PLA as both treatments had greater velocity and vasodilation 
than CAF. Caffeine is known to be a vasoconstrictor but there was no difference between PLA 
and PRE.  
Major limitations of the study included gender specificity as a small group of male 
participants were examined. Participants were further unwilling to give up the use of other 
supplements for washout periods. Second the time of day (0600 – 1000) was difficult for both 
caffeine restrictions and fasting requirements. Participants regularly consumed caffeine daily and 
were not able to consume breakfast prior to each trial. Third the lumen identifying markers V-r2 
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and V-C could only be analyzed on the ultrasound machine. Finally, the rest period could have 
been longer to better accommodate resting heart rate, resting blood pressure, and other baseline 
measures. Future studies should use 30 to 60 instead of 15 minutes rest prior to baseline 
measures. 
Future research and practice identifying the effectiveness of individual ingredient 
compared to multiple ingredient research. Further investigations should be gender indifferent 
including both male and female participants. Research related to NO, l-arginine, nitrate and 
nitrite in anaerobic exercise. 
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APPENDIX B. INFORMED CONSENT 
NDSU North Dakota State University 
  Health, Nutrition, and Exercise Sciences  
  Department # 2620, PO Box 6050 
  Fargo, ND 58108-6050 
  701-231-6706 
 
Title of Research Study: Ergogenic Potential of a Pre-Workout Dietary Supplement Combined 
with Resistance Exercise 
This study is being conducted by:  Principal Investigator- Kyle Hackney, PhD, CSCS, 
kyle.hackney@ndsu.edu, 701-231-6706.Co-investigator- Sherri Stastny, PhD, RD, CSSD, LRD, 
sherri.stastny@ndsu.edu, 701-231-7479. 
Why am I being asked to take part in this research study?  
We are looking to recruit 20 participants for this study. 
 
You are being asked to participate in this study because you: 
• Are a male between 18-35 years of age. 
• Are apparently healthy as identified by two health questionnaires.  
• Are a habitual caffeine user as identified by a nutrition questionnaire. 
• Have participated in resistance exercise, weightlifting, or weight training for a minimum 
of 2 days per week for the past 6 months.  
 
You should not participate in this study if you: 
• Answered “Yes” to any questions on the Physical Activity Readiness Questionnaire. 
• Are a current tobacco-user/ e-cigarette user 
• Are currently taking any prescription medications that interact with caffeine. 
• Are currently taking anabolic steroids or corticosteroids (such as Flovent for asthma). 
• Have any current or previous cardiovascular, musculoskeletal, or neurological medical 
problems. 
• If you are known to have had violent allergic reactions to drugs, chemicals, or food 
ingredients including milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, and soybeans. 
• Have consumed other dietary supplements (other than vitamins) within the past 3 weeks. 
 
What is the reason for doing the study?  Pre-workout dietary supplements containing L-
arginine nitrate claim to increase blood flow and enhance one’s ability to perform work. They are 
commonly used by many recreational exercisers in combination with resistance and aerobic 
exercise. This study will determine if a pre-workout supplement containing L-arginine does 
increase blood flow to the working muscle, alter energy metabolism, and result in greater work 
capacity compared to consuming caffeine alone or a placebo (inert substance).     
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What will I be asked to do?   
We are asking you to complete four testing trials. The first will last approximately 30 minutes 
and the remaining three will last about 2 hours. The first visit can be scheduled at any time that 
works for you and the research team. At this visit we will measure your height, weight, and arm 
strength. For the three longer visits, we will need you to arrive at the laboratory at approximately 
7:00am without having eaten food or had any liquids other than water. You are, however, free to 
drink as much water as needed. Will also place 10 electrodes on your chest in order to monitor 
your heart via an electrocardiogram. Then we will ask you to sit in a testing chair and take a 
survey regarding your current mood. We will then measure the blood flow occurring near your 
elbow using an ultrasound machine. Next, we will ask you to spit a small amount of saliva in a 
test tube so we can measure different physiological markers. After this measure, the finger on 
your left hand will be wiped with an alcohol pad and a small blood sample (an amount that 
would fill a contact lens) will be obtained from one of your fingers (finger prick). This will be 
done to examine your blood lactate levels, which is an indicator of metabolism. Following the 
finger stick a band-aid will be placed over the site. Finally, we will measure your blood pressure 
using an inflation cuff. After these measures you will drink approximately 10 oz of liquid 
containing either the pre-workout dietary supplement, caffeine only, or a fruit punch flavored 
placebo. After drinking the beverage there will be a 30 minute period of rest where you can use 
the restroom, check email, and/or complete homework/study. After 30 minutes, we will repeat 
the electrocardiogram, blood flow via ultrasound, finger stick for lactate level, and blood 
pressure measures.  
Next, we will ask you to perform resistance exercise with your right arm. A brief warm-up will 
be provided prior to this effort. Once the weight is determined we will ask you to perform 5 sets 
of 10 repetitions with 60 seconds between each set.  
Immediately post-exercise the following measures will be obtained: electrocardiogram, blood 
flow via ultrasound, finger stick for lactate level, and blood pressure.  
At 60 minutes post-beverage consumption (approximately 20 minutes post-exercise) the 
following measures will be obtained: mood survey, electrocardiogram, blood flow via 
ultrasound, saliva sample for physiological markers, finger stick for lactate level, and blood 
pressure. 
Once all measurements are completed you will be unhooked from all equipment and released 
from the study. At your next visit, everything will be the same except a different beverage will 
be provided. Neither you nor the researchers will know the order of the beverages.  
 
Where is the study going to take place, and how long will it take? 
This study will take place in room 14 of Bentson-Bunker Fieldhouse. The estimated time for 
each session is as follows: 
Visit #1 = 30 minutes 
Visit #2 = 120 minutes 
Visit #3 = 120 minutes 
Visit #4 = 120 minutes 
It is estimated that the total time for this study will be ~390 minutes (6.5 hours). 
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What are the risks and discomforts?  
It is not possible to identify all potential risks in research procedures, but the researchers have 
taken reasonable safeguards to minimize any known risks to the participant. If new findings 
develop during the course of this research which may change your willingness to participate, we 
will tell you about these findings. Below are examples of known risks for this study.  
 
Muscle Strength Testing and Resistance Exercise 
1. Muscle soreness following testing- Exercising with higher than accustomed resistance, 
performing new exercises, maximal exercises, or performing eccentric (muscle lengthening) 
movements (risk- moderate). 
2. Muscle cramping- Inadequate warm-up or stretch may cause cramping (risk- low). 
3. Musculoskeletal injury during testing- Muscle overload or improper performance of a test 
can cause muscle, ligament, tendon, or bone injury (risk- low). 
4. Adverse cardiovascular responses- Abnormal blood pressure responses from holding ones 
breathe to help generate force or from the standard exercise (risk-low). 
5. Lightheadedness- Quickly standing following exercise or the strain of standard exercise 
(risk-low). 
6. General personal injury- Inadvertently walking into test stations during operations, having 
contact with sharp edges, pinch points, or hardware/software failure could cause injury (risk-
low). 
Dietary Supplement, Caffeine, or Placebo Intake 
1. Nausea- Upset stomach from known or unknown ingredient in dietary supplement or placebo 
(risk- moderate). 
2. Allergic reaction- to known or unknown ingredient in dietary supplement or placebo (risk- 
low). 
3. Adverse cardiovascular responses- Abnormal heart rate or blood pressure responses from 
dietary supplement or placebo (risk-low). 
Measurements 
1. Mood change- caffeine is known to influence mood and may acutely elevate vigor, 
awareness, but also irritability (risk moderate). 
2. Rash or skin irritation -At the site of application of the ultrasound gel or from alcohol 
preparation pads or electrodes (risk-low). 
3. Infection- At the site of the finger stick (risk-low). 
Risk Minimization  
The study team has minimized the known risks by studying healthy, participants that are habitual 
caffeine users with resistance exercise experience. By being healthy and used to resistance 
exercise all exercise testing risks are lowered. We will also monitor heart rate and stop the 
session if your heart rate is raised above your age predicted heart rate (220-age) for more than 30 
seconds. For lactate samples, safety lancets, gloves, proper cleaning of fingers with alcohol, and 
post-finger stick wound coverings will reduce the risk of infection. If you are known to have had 
violent allergic reactions to drugs, chemicals, or food ingredients, you should not take part in this 
study. We will use non-allergenic ultrasound gel to reduce the risk of rash or skin irritation.  If 
redness, swelling, or bruising occurs at any sites during this study please contact Kyle Hackney, 
NDSU: 701-231-6706   or cell: 616-886-0226 or call Student Health Services directly at 701-
231-7331. If you feel it is a medical emergency call 911.  
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What are the benefits to me?  
You are not expected to get any benefit from being in this research study. 
What are the benefits to other people?  Pre-workout dietary supplements are sold at many 
stores and online; and are common practice in fitness facilities/gyms. It is important to conduct 
research to validate or refute the advertising claims made.  
Do I have to take part in the study?  Your participation in this research is your choice.  If you 
decide to participate in the study, you may change your mind and stop participating at any time 
without penalty or loss of benefits to which you are already entitled. 
 
What will it cost me to participate?  There are no direct costs for participation in the study. 
What are the alternatives to being in this research study? Instead of participating in this 
research study, you can choose not to participate. 
Who will see the information that I give?   
We will keep private all research records that identify you. Your information will be combined 
with information from other people taking part in the study.  When we write about the study, we 
will write about the combined information that we have gathered.  We may publish the results of 
the study; however, we will keep your name and other identifying information private.   
We will make every effort to prevent anyone who is not on the research team from knowing that 
you gave us information, or what that information is.  For example, your name will be kept 
separate from your research records and these two things will be stored in different places under 
lock and key. If you withdraw before the research is over, your information will be retained in 
the research record and we will not collect additional information about you.   
Can my taking part in the study end early?  
You can choose to not be in the study at any time, however, we ask that you please contact the 
researchers if you choose to do so. If you fail to show up to sessions or fail to comply with the 
study guidelines you may be removed from the study. 
Will I receive any compensation for taking part in this study? Compensation of $40.00 after 
completion of this study (all 4 visits). 
What happens if I am injured because of this research?  
If you receive an injury in the course of taking part in the research, you should contact Kyle 
Hackney at the following phone number NDSU 701-231-6706 or cell 616-886-0226.  If an injury 
should occur first aid will be administered as well as contact of emergency services (911). 
Payment for this treatment must be provided by you and your third party payer (such as health 
insurance). This does not mean that you are releasing or waiving any legal right you might have 
against the researcher or NDSU as a result of your participation in this research. 
 
What if I have questions? 
Before you decide whether to accept this invitation to take part in the research study, please ask 
any questions that might come to mind now.  Later, if you have any questions about the study, 
you can contact the researcher Kyle Hackney, kyle.hackney@ndsu.edu, NDSU 701-231-6706 or 
cell 616-886-0226.   
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What are my rights as a research participant? 
You have rights as a participant in research. If you have questions about your rights, or 
complaints about this research you may talk to the researcher or contact the NDSU Human 
Research Protection Program by: 
• Telephone: 701.231.8995 or toll-free 1-855-800-6717 
• Email: ndsu.irb@ndsu.edu 
• Mail:  NDSU HRPP Office, NDSU Dept. 4000, PO Box 6050, Fargo, ND 58108-
6050. 
The role of the Human Research Protection Program is to see that your rights are protected in 
this research; more information about your rights can be found at:  www.ndsu.edu/irb .   
 
 
Documentation of Informed Consent: 
You are freely making a decision whether to be in this research study.  Signing this form means 
that  
1. you have read and understood this consent form 
2. you have had your questions answered, and 
3. you have decided to be in the study. 
 
You will be given a copy of this consent form to keep. 
 
 
              
Your signature        Date 
 
 
         
Your printed name  
 
 
              
Signature of researcher explaining study      Date 
 
 
         
Printed name of researcher explaining study   
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Documentation of release of video or images: 
You also have the choice to allow all images and/or video obtained during this study to be used 
by the research team in publications, manuscripts, poster presentations, PowerPoint 
presentations, and University websites. Images will only be used in a professional context when 
describing the study. You name will never be associated with the image/video. 
 
Yes _______ 
 
No  _______ 
 
 
___________________________________________   _________________ 
Your signature        Date 
 
         
Your printed name  
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APPENDIX D. RECRUITMENT FLYER 
 
 
105 
 
105 
APPENDIX E. RECRUITMENT EMAIL SCRIPT 
Ergogenic Potential of a Pre-Workout Dietary Supplement Combined with Resistance 
Exercise 
Principal Investigator- Kyle Hackney, PhD, kyle.hackney@ndsu.edu, 701-231-6706. 
Co-investigator- Sherri Stastny, PhD, RD, sherri.stastny@ndsu.edu, 701-231-7479.  
 
Pre-workout dietary supplements containing caffeine and L-arginine nitrate claim to increase 
blood flow and enhance one’s ability to perform work by stimulating vessels to produce nitric 
oxide. Today, pre-workout supplements are commonly used by many recreational exercisers in 
combination with resistance and aerobic exercise. This study will determine if a pre-workout 
supplement containing L-arginine does increase blood flow to the working muscle, change 
energy metabolism, alter mood, or result in greater work capacity compared to consuming 
caffeine alone or a placebo (sugar pill).     
 
We are looking to recruit 20 participants for this study. To participate you should be a male 
between 18-35 years of age, generally healthy, a habitual caffeine user (equivalent to about one 
large cup of coffee per day), have participated in resistance exercise, weightlifting, or weight 
training for a minimum of 2 days per week for the past 6 months.  
 
We are asking you to complete one laboratory familiarization session and three testing trials 
where you will be randomly assigned to consume a pre-workout supplement, caffeine only, or 
placebo. During each trial, we will measure your heart rate (using electrocardiogram), arm blood 
flow (using ultrasound), mood (survey), nitric oxide level (saliva sample and strip), and whole 
blood lactate (figure stick and test strip) before and after upper body resistance exercise. Each 
testing trial will last approximately 2 hours.  
 
Compensation of $40 will be awarded for full completion of the study. If interested or for more 
information please contact Michael Blake at E-mail- michael.blake@ndsu.edu, Phone- 701-231-
9749.This research has been approved by the North Dakota State University Institutional Review 
Board (Protocol #HE15244). 
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APPENDIX F. PRE-WORKOUT DATA SHEET 
  
Pre-Workout Data Sheet 
 
 
Participant (#) ___________   Date___________   Trial (#) ____________ 
_____________________________________________________________________________ 
Height_________________                          Weight__________________ 
POMS Survey Pre-Supplementation Time _______     POMS Survey Post-Supplementation 
Time ______  
Product Consumption Time ________                                      Exercise Start Time _______ 
Subject Discharge Time ________ 
Biodex Measures: 
• Elbow Extension ________________      50% __________________ 
• Elbow Flexion     ________________       50% __________________ 
Biodex Seat Measurements:  
  
  
  
  
ECG Data Collection-  
Pre-Supplementation (5 minutes 
resting during POMS) 
 
30 minutes after 
supplementation 
 
Post exercise  
60 minutes post-
supplementation 
 
 
POMS PRE POST 
Anger (0-48)   
Confusion (0-28)   
Depression (0-60)   
Fatigue (0-28)   
Tension (0-36)   
Vigor   
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Blood Pressure, Heart-rate, and Lactate Measures: 
 Blood Pressure Heart-Rate Lactate 
Pre-Supplementation    
30 minutes after 
supplementation 
   
Post exercise    
60 minutes post-
supplementation 
   
 
Ultrasound measures:  
 Pre 
Sup 
30 min 
post sup 
Post 
exercise 
60 min 
post 
exercise 
 
Systolic      Comments: 
Diastolic      
Mean Velocity      
AT      
TAVM      
S/D      
RI      
PI      
Vessel 
Diameter 
     
Vessel 
Circumference 
     
 
Nitric Oxide Measures: 
 Color availability of nitric oxide in 
system 
Pre-Supplementation   
30 minutes after 
supplementation 
  
Post Exercise   
60 minutes post-
supplementation 
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APPENDIX G. DATA COLLECTION CHECKLIST 
Subject ________Date _______________    Researchers at data 
collection (initials) 
Before subject arrives 
---------------------------------------------------------------------
-- 
_____ ECG “On” 
_____ Biodex “On” 
_____ POMS Laptop on and connected to internet 
_____ Lactate analyzer and testing strips prepared 
_____ Nitric oxide strips and equipment ready 
_____ Ultrasound “On” 
_____ Blood pressure cuff ready 
_____ Supplement ready 
_____ Cold water ready 
------------------------------------------------------------------------- 
Subject arrives 
_____ Informed Consent 
_____ PARQ 
_____ Health History Questionnaire 
_____ Caffeine and Nutritional Compliance Questionnaire 
_____ Height 
_____ Weight  
_____ ECG preparation and hook-up 
_____ Biodex Fitted for subject- subject playing on computer 
---------------------------------------------------------------------------------------------------------------------
------- 
Pre- data collections 
_____ ECG data collection 5 minutes during POMS (Pre)- save as sub#_pre_date 
_____ Initiate POMS survey (Pre, screen shot and save as Sub#_pre_date 
_____ Ultrasound measures (Pre)- process later record on data sheet 
_____ Lactate measures (Pre)- record on data sheet 
_____ Nitric Oxide (Pre)- record color on date sheet 
_____ Blood Pressure measurement (Pre)- record on data sheet 
_____ Consume product---------------------------------- Record time here  
 
At 30 minutes post-intake - Start data collections -Record time here  
_____ ECG data collection 5 minutes during POMS (30)- save as sub#_ 
30_date 
_____ Ultrasound measures (Pre)- process later 
_____ Lactate measures (Pre)- record on data sheet 
_____ Blood Pressure measurement (Pre)- record on data sheet 
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Get ready for Exercise 
_____ Biodex strength Test  
_____ ECG data collection On “Exercise” 
_____ Biodex Resistance Exercise 
_____ ECG data collection Off “Exercise”, save as sub# exercise 
Immediately Post obtain 
_____ECG data collection sub# post-ex_date 
_____ Ultrasound measures (Post-ex), process later 
_____ Lactate measures (Post-ex) 
_____ Blood Pressure measurement (Post-ex) 
Wait until 60 minutes post Pre-workout intake. Start data collections Record time here 
_____ ECG data collection On, save as sub#_60_date 
_____ Initiate POMS survey (Post-60, screen shot and save data as sub#_60_date 
_____ Ultrasound measures (Post-60), process later 
_____ Lactate measures (Post-60) 
_____ Nitric Oxide (Post-60) 
_____ Blood Pressure measurement (Post-60) 
Unhook subject from all devices 
_____ Give subjects discharge instructions 
_____ Subject data collection complete 
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APPENDIX H. DISCHARGE INSTRUCTIONS 
Pre-workout Study Subject Discharge Instructions.      
          
 Date_____________ 
Dear Study Participant:  
Please be aware that you may have just completed a trial consisting of a minimum dose of 350 
mg of caffeine. For your safety please avoid other foods/drugs that may also contain large doses 
of caffeine for 24 hours. Examples are provided below. Also, please avoid consumption of any 
alcoholic beverages for 24 hours as alcohol consumption may lead to dehydration.  
 
*caffeine content in some items can vary. Value estimates obtain from Appl. Physiol. Nutr. 
Metab. Vol. 22, 2008. 
Although the influence of a high caffeine intake is temporary (~12 hours) and we do not 
anticipate any study related problems, if you experience nausea, persistent rapid heart rate, chest 
pain, or other bothersome side effects, please seek medical attention (your personal provider) and 
contact the research team. 
If you have any questions, do not hesitate to call or email.  
 Thank you,  
 
 _______________________     _______________________ 
 Dr. Kyle Hackney, PhD, CSCS     Dr. Sherri Stastny, 
PhD, RD 
Food or Drink Serving Caffeine, mg (variability)* 
Instant Coffee 250 mL (8oz) cup 60 (12-169) 
Brewed Coffee 250 mL (8oz) cup 80 (40-110) 
Expresso 1 standard serving 107(25-214) 
Starbucks Breakfast Blend 600 ml (20 oz) 415(300-564) 
Iced coffee 500 ml (16 oz) 30-200 
Frappuccino 375 ml (12oz) cup 90 
Tea 250 ml (8 oz)  27 (9-51) 
Hot Chocolate  250 ml (8 oz) 5-10 
Coca Cola 375 (12 oz) can 49 
Red Bull Energy drink 250 ml (8 oz) 80 
AMP Energy drink 500 ml (16 oz) can 143 
Fixx energy drink 600 ml(20 oz) can  500 
No-Doz (U.S.) 1 tablet 200 
Extra Strength Excedrin 1 tablet 65 
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 Kyle.hackney@ndsu.edu     Sherri.stastny@Ndsu.edu  
 701 231 6706       701 231 7479 
***This signature form should remain in the research lab 
I was informed that I should avoid foods/drugs containing large amounts of caffeine and alcohol 
for 24 hours.   
___ Yes 
___ No 
Trial 1 
Participant Name (please print)       
Participant Signature _____________   Date _________________ 
Trial 2 
I was informed that I should avoid foods/drugs containing large amounts of caffeine and alcohol 
for 24 hours.   
___ Yes 
___ No 
Participant Name (please print)       
Participant Signature _____________   Date _________________ 
Trial 3  
I was informed that I should avoid foods/drugs containing large amounts of caffeine and alcohol 
for 24 hours.   
___ Yes 
___ No 
Participant Name (please print)       
Participant Signature _____________   Date _________________ 
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APPENDIX I. MODIFIED PROFILED MOOD STATES 
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